ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000414.1|Quinocarcin_1 # 179 # 595 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.674	BGC0000414.1|Quinocarcin_1 	179	595	-	Loose	600	25.0238	SGM-3	28.57	3006989	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SGM beta-lactamase	GTGGAGTACCCGGTCGAGCCCGATCCGGCATGGCTGGCCGCTCACCACTGGAACTGGGACGGTGTCCGGCTCGACGTGCTCCTGCGCGGGGCGGGCGGCACGCTGTTCGTGTGCGGTAACGCCTTCAACGTCATGGAGTTCGTCCCACGCTTCGCTCTCGTGATCCTCCTGGAACTGGACACCGGGACCATGCTGCGCCGGGTGTCCTCACGCGGCACGACATTCGGGCGCACCAGTGCCACCCGCGCGTGGCTGCTCGGCTGGGCGCCCGGATTCCAGAGGAACATCAAGCGGCTCGGAACGAGGGCGGTCGATGCCCGGCTTCCGGCAAAATGCGTTGCCGATACCGTGATCCGCCTCTCCGACGAACAGGGACTGATCGATTCCGGCGAGCGCGAAAGGCCCGACGGTCCGTGA	MEYPVEPDPAWLAAHHWNWDGVRLDVLLRGAGGTLFVCGNAFNVMEFVPRFALVILLELDTGTMLRRVSSRGTTFGRTSATRAWLLGWAPGFQRNIKRLGTRAVDARLPAKCVADTVIRLSDEQGLIDSGERERPDGP	MPRRLIFAALLLAAPAAAQQEAPRPSLLPPPPRYMVSESAMRSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCSTFKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLPMVGGPEGLTRFIRAHDDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPKGWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFVDKAQKTGLE	44.66	gnl|BL_ORD_ID|4576|hsp_num:0	5646			315	441	
BGC0000414.1|Quinocarcin_2 # 783 # 1103 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.710	BGC0000414.1|Quinocarcin_2 	783	1103	+	Loose	400	22.7126	ErmV	27.5	3002824	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGGGGCGCGCCGGGCGGGGCAGGGCGGCGCCGCGATCGGCGGGGTTCCCCCGGCCGGGCGCGTTCCCCGGACCCGCGCCGACCGCGTGGAGCACCGCGTCCCTACCTCGTCGGCCTGTCCGGGGCGGCGGACGAGCCCGGTGACCTGCCGTCCCCGGGCTGCGAGCAGACGGGGCACGGCGAGTGCGACCCGGCCGTGACCACCGGCGATAACCACACGCACATCACAAATAGTAATAATGAGTGGGCTATGCGTTCAATTCGGTATGCGAGTAGCGGTACGAGCTGTGCAGTTCTCGCCCGCGACACCGCCTGTTGA	MRGAPGGAGRRRDRRGSPGRARSPDPRRPRGAPRPYLVGLSGAADEPGDLPSPGCEQTGHGECDPAVTTGDNHTHITNSNNEWAMRSIRYASSGTSCAVLARDTAC	MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSLLAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS	40.93	gnl|BL_ORD_ID|1095|hsp_num:0	1188			90	210	erythromycin; tylosin; oleandomycin; chalcomycin; kitasamycin; carbomycin; celesticetin
BGC0000414.1|Quinocarcin_4 # 3095 # 3694 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.683	BGC0000414.1|Quinocarcin_4 	3095	3694	+	Loose	2000	25.0238	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	29.41	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGTCCGGCAAGGCCAAGAACTCACTGGAGAAGTACCGTTCCAAACGGCATGCCGGCCGGACGCCCGAGCCGATGGGCGGCAGCTCGCGCAGAGCGGGCAGGCGGCGCTTCGTCGTGCAGAAGCACGCTGCGTCCTCCCTGCACTACGACTTCCGGCTCGAGGCGGGTGGCGTGCTGAAGTCCTGGGCCGTACCGAAGGGGCCCTCGACCGACCCGCGCGAGAAGCGCCTGGTCATGCGCACCGAGGACCACCCCGTGGGCTACGTGGACTTCGAAGGCGTCATCCCGGAGGGCGAGTACGGGGCAGGGCAGGTCATCGTCTGGGACACGGGCACATACCGGAACCTGACCGAGCGCGACGGCAAGAAGGTTCCCGTGTCCAAGGGGGTGAACGAGGGGCACATCAAGGTGTGGCTGGAGGGGGAGAAGCTCCCCGGCGGCTACGCGCTGACGTGTACGGGGCAGCGAGGCGGGCAGGAGCGGTGGATTCTGGTGAAGGTTTCCGATGCGGGGGCTGATGCCCGTCGCAACCCTGTGAGTTCCCAGTCGGCGTCGGTGCAGTCCGGCCGTACTGCGGAGGGCGTCGCCGAGGACGCCTGA	MSGKAKNSLEKYRSKRHAGRTPEPMGGSSRRAGRRRFVVQKHAASSLHYDFRLEAGGVLKSWAVPKGPSTDPREKRLVMRTEDHPVGYVDFEGVIPEGEYGAGQVIVWDTGTYRNLTERDGKKVPVSKGVNEGHIKVWLEGEKLPGGYALTCTGQRGGQERWILVKVSDAGADARRNPVSSQSASVQSGRTAEGVAEDA	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	16.78	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2373	2661	rifampin
BGC0000414.1|Quinocarcin_6 # 6515 # 9256 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.736	BGC0000414.1|Quinocarcin_6 	6515	9256	+	Loose	750	29.6462	adeA	29.87	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCCTGTACCGCCGCAGCCGGGCGAGGAGCGGGAGGCGAGAGGTGAGTGAGCAACGATTCTCGGTGAACGGCCGGTCCCACCACATCGACGTCCGTGAGGACGAGACCGCCCTCGACGTCGTACGCGACGGGCTCGGCCTGACCGGTGCCAAACGCGTCTGCGAGGCGGGCGCTTGCGGAGCCTGCGCCCTGCTCGTGGACGGAGTGCCCTCGGCGAGCTGCCTGATCCCGGCCGATGCCCTGGACGGTGCGGCGGTCACCACTGTGGAGGGTGTCGCCGATCCGTCCAGGCTCCACCCGGTGCAGCTGGCCCTCATGGCCGAGGACGCCGTCCAATGCGGCTACTGCACCCCCGGCTTCGTGGTCTCGGCCGTGGCCTTCCACGACACCTGGCGACGGGAGCACGACCGCGGGCGTCCCTCGGTCGAGGAAGTGCGCCGGGCACTCGCCGGCCATTTGTGCCGGTGCGGTTGTTACTTGCGGATCGTGGAGGCGGTCCGTGCCGCCTGCGAGGGGCGCTACGACAGCACCGACGCCACCCCCCGGCGGCACGAGGCGCGGGAGAAGGTCACCGGCCGCGCCCGCTACACCACCGACGTCCGCCACCCCGGCCAGCTGGAAGGGGTCGTCGTCACCTCGCCCGTGGGCAACGCCGTGGTCCATGACATCGACGACTCGACGGCCCGGTCCATGCCGGGCGTGCACGCTGTGGTCCGGCTGCTCGCCGACGACGGCAAGGTCCGTTACGCGGGCCAGGAGGTGCTGGCCGTGGCCGCCGACACGCTGCCGCTGGCCCGCGCGGCCGCCGCTACCGTGAAGATCGTCTGCACGGGCGGGCCCGTCGTCACCGGCATGGACCGGGCACGGGCCGACGACGCCCCGCTCGTGTACGGGGCCGAGGAGCGCGGGAAAGCACCCTCGGCGGGTGAGGTGCCCGTCCTGTTCGGCCGGTGGACTTGGCGCGGCAACGTCCGCGCCCCCAAACCGCCGGTGCCCGGTACCCGGGCCGCTCGACGGGGCCGACAAGTCCGCGCCGTGTGCGCCGGGCCCGGAGCGGACCCCCGTGGCGGCGACGCGCAGACAGTCTCGAGTGTGTGGACCACCTCCGCGCAGAGCCATGTGCCTCTCGAACCGCACGCCTGCGTCGCCTCCTGGGACGACGACGGACTCACCGTCCATCTGTCCACCCAGGGCGTCGGGATGATGGCCCACGCCATCGCTCGCCGCTGGAAACTGAAATCCCGTCAAGTACGGGTCCTCGCCGAACACGTCGGGGGCGCCTTCGGCGCCAAGCAGACCCTCACTGCCGAAGCCGTTGCGGCTGTCGAACTCTCCCGTGCCACCCGACGCCCCGTACGGGTCGCCCTCGGCCAGCGCGACGAACTCGCCATCGGCGGGAACCGGCCCGGCACCGAGACCCACCTGGCCCTGGCCGCAGGACCGACCGGCGACCTCCGGGCCCTGAGCGCCGACGCGTACGCAGCCACCGGTGCGGCCGTCGGCTCCGAGGTGGCGCAGTTGTGTGGCCTGCTGTACCCCGGGCCGCCCCGGCTGTTGCGCGACCACAGCGTCCTCACCCACACCCCGCCGGGCAAACCCTTCCGCGCGCCCAGCGGACCACCCGCGTTCTGGGCGCTGGAGCAGGCCATCGACGAGATGGCCCACCGTTTCGGCGAGGACCCGCTGGACCTGCGTCGTCGCTGGGACACCGAACCCGTGCGGCGACGCCTGTACGACTGGGCCGACGAGGCCACGCCCTGGCGCGCCCGCGGCCCCGTCGCCGTCGACACCGGCCCCCTGCGCCGCGGTCTCGGGCTCGCCACCGCCTCCTGGTACTACTACCTGCAGCCGCTCACCCGGGTCCGGGCCGCCGTGGACGACGGGGGGCTCGTCGTGAGCGTCGCGCTCCAGGAGATCGGCACCGGCTGCCGCTCCGTCCTGGTGTCCGTCTTCGCCGACGCGTTCGGGCTGGCACCCGCCGAGATCCGGGCCCGTATCGGGGACTCCCGGCTGCCGCGCGGACCCCTCGCAGCCGGGAGCAGCACCACGGCGTCCGTGGTGCCCGCAGCCCACGACGCCGCCGCCCGCCTCAAGGCACGCGTGACGTCCGTCGTGGCACGCGACCGCGGCCTGACCGGCGCCCGCCCCACCGCCGACGGCATCCGGCACGCCGCCGGCACCATCGGCTGGCGCGAGGCTCTCCACGCGGCGGCACCCGTAGAGGTGACCGGCCGACGTCCCCGCGACGCGGGACCCCGGCCACGTCCGTGGTACTCGCCGTTCTTCGGCCGCGGCCGCGGCACGCCGAGCATCGTGCAGGTCACCGAGGTCGAGGTCGACGAGCGGTACGGACTCGTCCGGGCCGTAAGGACGTGGTGCGCGCTCGCGGCCGGGCGACCCGCGCGGCCGGAGCTGGCGACCACCCAGGTGCACGGCGCTGTCATCCAGTCCCTCGGCCAGACCCTGTACGAAGAACGTCTGGTGGACCCGGCCACCGGCGTCACCCTGCCCGTGAGTCTGGAGAACTACGCCGTCCCTGGCATCGCGGACGTCCCGGAGATCGAGGTCGCCTTCCTCGATGGCGGTTTCGGACACGTGCCGCAACAGGCCGTCGGCATCGCGGAACTCGCGGCCCTGACCACTCCGGCCTCCATCGGCAACGCTGTCTTCCACGCGACCGGCCGCCGTCTGCGGTCGCTGCCGCTGCGTCCTGGCCCACTCCTGGAGAGGGAACGATGA	MGLYRRSRARSGRREVSEQRFSVNGRSHHIDVREDETALDVVRDGLGLTGAKRVCEAGACGACALLVDGVPSASCLIPADALDGAAVTTVEGVADPSRLHPVQLALMAEDAVQCGYCTPGFVVSAVAFHDTWRREHDRGRPSVEEVRRALAGHLCRCGCYLRIVEAVRAACEGRYDSTDATPRRHEAREKVTGRARYTTDVRHPGQLEGVVVTSPVGNAVVHDIDDSTARSMPGVHAVVRLLADDGKVRYAGQEVLAVAADTLPLARAAAATVKIVCTGGPVVTGMDRARADDAPLVYGAEERGKAPSAGEVPVLFGRWTWRGNVRAPKPPVPGTRAARRGRQVRAVCAGPGADPRGGDAQTVSSVWTTSAQSHVPLEPHACVASWDDDGLTVHLSTQGVGMMAHAIARRWKLKSRQVRVLAEHVGGAFGAKQTLTAEAVAAVELSRATRRPVRVALGQRDELAIGGNRPGTETHLALAAGPTGDLRALSADAYAATGAAVGSEVAQLCGLLYPGPPRLLRDHSVLTHTPPGKPFRAPSGPPAFWALEQAIDEMAHRFGEDPLDLRRRWDTEPVRRRLYDWADEATPWRARGPVAVDTGPLRRGLGLATASWYYYLQPLTRVRAAVDDGGLVVSVALQEIGTGCRSVLVSVFADAFGLAPAEIRARIGDSRLPRGPLAAGSSTTASVVPAAHDAAARLKARVTSVVARDRGLTGARPTADGIRHAAGTIGWREALHAAAPVEVTGRRPRDAGPRPRPWYSPFFGRGRGTPSIVQVTEVEVDERYGLVRAVRTWCALAAGRPARPELATTQVHGAVIQSLGQTLYEERLVDPATGVTLPVSLENYAVPGIADVPEIEVAFLDGGFGHVPQQAVGIAELAALTTPASIGNAVFHATGRRLRSLPLRPGPLLERER	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	230.56	gnl|BL_ORD_ID|1210|hsp_num:0	1313			597	828	tigecycline; tetracycline
BGC0000414.1|Quinocarcin_8 # 10229 # 11140 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.673	BGC0000414.1|Quinocarcin_8 	10229	11140	-	Loose	520	25.0238	OXA-478	30.3	3003635	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAGGACTATCGGTGTTCAAGGAAGCCCAGTTGTTCGCGCCGCTCGTCATCGATGCAGCCGGAACTCCTGACGTCACCTTCCCGCCGGGCCATCCGGGTGCCGGCGACGATGAGTACCGCATGCACCGCAACGAGATCGCCGCCGCTGCCCTGGCGTACCGGGACGGCGATCCACTGCCCGACATCGGGTATACGCCCCGCGACCACGACACCTGGCGCCGGATCAGTGCGGCGCTGGCCTCGCTGCACCGGGAGTTCGCCTCCACCGAGGCCCGGGACGCTGCAGAGCGGCTGGCACTGCCCGCGGACCGGGTGCCGCAACTGAGCGAGGCGTCACGTCGGCTGGAGCACCTCACCGGTTTCACGTTGCGCCCGGCGGCCGGGATCGTGCCGCTGAGTGAGTTCTACGGGTCACTCGCGGACTGCATGTTCCACGCCACCCAGTTCATCCGGCACCCGTCCAAGCCTCTGTTCTCCCCCGAGCCTGACATGGTGCACGAGGTGATCGGCCACGGCACCACTCTGGCGAGCAGCCGTTTCGCCAAGCTGTACCGGCAGGCGGGCGAGGCGGCCCGGCGCGCGGGCAACGGGACGTCCCTCAAGGCCGTGTCGCGGGTGTTCTGGTTCACACTCGAGTACGGAGTCATGGAAGAGAATGGCCAGTTCATGGCGTATGGGGCGAGCCTGCTGTCGGCCTACGGGGAGCTGCAGAGCTTCCGGGGCGTGGAGATACGCCCGTTGGACGTGCGCGACATGGTGACCCGGCCGTACGACGTCACCTCGTACCAGCCGGTACTGTACGCCGCCGAGTCCCTGGCACATCTGGAGGATTTCCTCGGCGAGTTCTCTTCCGGGGTTGACGGCGACACCGGAGACCGGCTGGGTCTGGTACCTGGCGAGAAGTGGTAG	MKGLSVFKEAQLFAPLVIDAAGTPDVTFPPGHPGAGDDEYRMHRNEIAAAALAYRDGDPLPDIGYTPRDHDTWRRISAALASLHREFASTEARDAAERLALPADRVPQLSEASRRLEHLTGFTLRPAAGIVPLSEFYGSLADCMFHATQFIRHPSKPLFSPEPDMVHEVIGHGTTLASSRFAKLYRQAGEAARRAGNGTSLKAVSRVFWFTLEYGVMEENGQFMAYGASLLSAYGELQSFRGVEIRPLDVRDMVTRPYDVTSYQPVLYAAESLAHLEDFLGEFSSGVDGDTGDRLGLVPGEKW	MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAELRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNSRYAIKNSQVPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFGIEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTYNYTLHGKTGLVDSKNMTTEPIGWFVGWLEENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	112.64	gnl|BL_ORD_ID|2095|hsp_num:0	3540			294	393	cloxacillin; oxacillin; cefalotin
BGC0000414.1|Quinocarcin_9 # 11193 # 11843 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000414.1|Quinocarcin_9 	11193	11843	-	Loose	400	35.8094	Erm(31)	34.12	3000598	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCGCGCCTCGCTGCTGCGGATGCTCTACGAAATCGAGCACCGCCTGCCCTTCAACATTGCACCGTCGAACGTGCCTGACCGGGACTTGCGGAAATTTCTGGAAGGGGATCCGAGACCGCTTCCGGGACGTGCCCTGGACCTCGGCTGCGGCAATGGCAGGAATGCCCTGTATCTGGCCCGCCATGGCTGGCAGGTGAGCGGCGTCGAACTGGTGGGGCACGCGGTGAAGGAGGCACGCCGCAAGATGGCGGCGGCCGGGGCCGACGTCCGAGTCGTGCACGGCGATGCGAGCCGGTTGTCCGACTACGACATGGGCGACGGCTTCGATCTGGTCGTGGACTCATGTTGCTACCACGCGGTGGCTGTGGAGCGGCGCGACGCCTATGCCGCGCAGGTGACGAAGGCAGCGGCTCCTGGCGCCCTCATGTTCATGGTGGCGTTCGTGGAGCAGAACACTCCCGGAATGAACGTCACGGAAGATGACTTGCGCAGTCGTTTCACCGGCTGGGAGATCCTGGAGACCGCGCCCGTGTCCGGTCAGGAGATGGCGGAGTACTACGACGGGCCCGCCTTCGCCAAAAGGACGTTGACGAATGGCCGTTACCGGGCCCGCCGTTACCGGATGCGACGCCTGGCCGACATCTCCTGA	MRASLLRMLYEIEHRLPFNIAPSNVPDRDLRKFLEGDPRPLPGRALDLGCGNGRNALYLARHGWQVSGVELVGHAVKEARRKMAAAGADVRVVHGDASRLSDYDMGDGFDLVVDSCCYHAVAVERRDAYAAQVTKAAAPGALMFMVAFVEQNTPGMNVTEDDLRSRFTGWEILETAPVSGQEMAEYYDGPAFAKRTLTNGRYRARRYRMRRLADIS	MAFSPQGGRHELGQNFLVDRSVIDEIDGLVARTKGPILEIGPGDGALTLPLSRHGRPITAVELDGRRAQRLGARTPGHVTVVHHDFLQYPLPRNPHVVVGNVPFHLTTAIMRRLLDAQHWHTAVLLVQWEVARRRAGVGGSTLLTAGWAPWYEFDLHSRVPARAFRPMPGVDGGVLAIRRRSAPLVGQVKTYQDFVRQVFTGKGNGLKEILRRTGRISQRDLATWLRRNEISPHALPKDLKPGQWASLWELTGGTADGSFDGTAGGGAAGSHGAARVGAGHPGGRVSASRRGVPQARRGRGHAVRSSTGTEPRWGRGRAESA	67.08	gnl|BL_ORD_ID|1068|hsp_num:0	1156			102	339	narbomycin; methymycin; pikromycin
BGC0000414.1|Quinocarcin_10 # 11950 # 14613 # 1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.707	BGC0000414.1|Quinocarcin_10 	11950	14613	+	Loose	1050	55.4546	lmrC	36.52	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	TTGCTCGATCTCACGGCTATTGTCCGGGGCTGGGCCCCACCGGTCGCACCAGCGAAGGGGAAGCAATCCATGTCGTCAGCCAGCCCGTCTCCCGAGACCAGCGGCGCCGGGTACATCGAGGTCGTCGGGGCGCGTACCCACAACCTCCGTAACGTGTCGGTCAAGGTGCCCCGTGACCGGGTGGTCGTCTTCACCGGGGTGAGCGGCAGCGGAAAGACCTCCCTCGCCATCGACACCATTCACGCCGAGGCACAACTGCGCTACCTGGAGGGCCTGTCGCCGTTCGTCCGGCAGTACATCAACCAGCGCAGCCGTCCCAAGGCCGACCGGATCACCGGGATCGGCGCCACGTTGGCCGTGGACCAACGGCGCACCAACCACAACCCCCGGTCCACCGTCGCCACCATCACCGGCATCGACGGCCACCTCGGACTGCTCTACTCCCGCCTGCCGGCGCTCGCCCCCGCCGACAGCACCGGTCCCGGTGGCACCACCGGTGTGGGCCGTACCCTGTCCACCGCCCACTTCGACCAGTACAGCCCCGAAGGCGGCTGCGAGGAGTGCCACGGAGTCGGCGGGACATGGCGCGCCGCCAAGGACCTGATCATCACCCACCCTCGACTCCCGCTGTTCCGCGGCGCCTCCCCGTGGTTCGCCAAATGGCGCTCAGGGGAGCACCGGTTCGTACCCGCGCTCGCCGAGAAGCGCGGCGTGGACCTCGAACAACCCTGGCAGGACCTGCCCCAGGCTTTCCGCGACGCCGTGCTGTACGGCACCGGCGACGAGGTCATCGAGGCCACGTACGAATTCCAGGCGCGCAAGAAGACCGGCAAGTGGACCTACAGCGACAAGGGACCGATGCGCGGCGCCCTCGCCGAGGTCGAACGCGTCGCTGGCGCCGCGTCCTCGCAGAGCGCCAAGCAGCGGTACATGGCGTACATGCGCAAGCAGCCCTGCGCCACCTGCGACGGCACCGGCTTCGGCGAGGCGGCCAGGACCGTCTCCCTGGGCGGCGTCAGCTACCAGCGGCTCGTCACCTTCGAGGTGGACACCGTCCGCAACTGGACCGGCGACGTCCTGGCGGGCCTGTCCGGCATGCAACGCGAGGTCGGCGAGCCGCTCCTGGAGGCGCTGGGCGCCCGGCTGACCCTGCTGCAGCGCCTCGGCGTCGGCCACGTGCAGCTCTTCCGCAGTGCCGCGTCCCTGTCCGGCGGGGAACTCCAGCGGACCCGGCTCGCCGCCCAGCTCAGCACAGACCTCACCGGCATGACCTTCGTCCTGGACGAGCCGGGCACCGGTCTGCACCCCGCCGACAAGGCACACCTGCTCGACATCGCCCACGAACTGCGCGGTAGCGGCAACACGGTCCTTCTGGTCGACCACGACCCCGAGCTGATCGCTCGGGCCGATTGGATCATCGACATGGGCCCCGGGGCGGGCCGGCTCGGCGGACACCTCCTGGCCTCCGGGCCGCCGGCCGAGATCAGCCGCTGCGAGGAATCCACCACCGGCCGTTACCTTGCCCGCCGTGGCCGCCGGGTGGACCGGATCCCGCGCCCGGTCGACGACCGCACCCCCTCGCTCGTCCTGCGCGCGGTCGAGGTTCACAACGTGACCGCTGACGAGATCCGGTTTCCCCTCGGCAGGCTCACCTGCCTGACCGGGGTCAGTGGCAGCGGCAAGAGCAGCGTCCTTCGCGACGTGCTCGGTGTCGGCGTCGCGGCCTGCCTCGACGGCGGCACCGCTGACACAGTGGGGCAAGTCGACGGAGTGGAACACCTCAGCTGGCTCGCTGTGGTCGACCAGGACCCCATCGGCCGCACCCCGCGATCCAACCCGGCCACCTACACCAAGGCGTTCGACATCATCCGGCGCCTCTTCGCCAGCGCCGACCAAGCACGAGCGCTCGGCCTCGACGCGTCCGCATTCTCCTTCAACGCCCCGGGCGGACGGTGCGAGGCGTGCACGGGATACGGCCGCAGACTGGTCGACATGCATTTCCTCCCCGATGTGTGGGTGATCTGCGATGCATGCGAGGGCCGCCGGTTCACTCCCGAGGTCCTCACCGTCACCTACCGGGGCCTGACCATCGACGCCGTCCTCGGTCTCACCGTCGCCGAGGCGGTGGAACACTTCCAGGAGCCGCGGCAACTGGCCACCACTCTACGGGCCCTCGACAAGGTGGGCCTCGGCTACCTACAGCTGGGCCAGAGTGCCACCGACCTGTCGGGCGGCGAGGCCCAACGGCTGAAACTTGCCAACGCCATCCAGCGCGGCACTCGAGGCCACAGCTCCGGACTCATCCTCATGGACGAGCCGGTGTCCGGCCTGCACCCGGCCGATATCCAGCAGATGGTCGATGCCTTCGAACTACTGCTGGAGGCGGGCCACACCGTGATCGTGGCCGAGCACGACCTGCACGTCGCGGCCGCTTCCGACTGGGTCGTGGACCTGGGCCCCGGCGCCGGAGCCGCGGGTGGCCGCGTGATGGCCGAGGGCCCCCCGCGCGAGGTCGCCCGCACCAACGGTGTCACCGCCGCCTACCTGCGACGCGTCGAGGCCGGCGAACCTCTGCTGGGCACGCAGGTGGTTCCGGGCACGCCGGTGCCCGGTACGCCCGGCGCGCCCCCGCAGGGTGAGTCCGGGCCCGCGGCCCGCGGCTGA	MLDLTAIVRGWAPPVAPAKGKQSMSSASPSPETSGAGYIEVVGARTHNLRNVSVKVPRDRVVVFTGVSGSGKTSLAIDTIHAEAQLRYLEGLSPFVRQYINQRSRPKADRITGIGATLAVDQRRTNHNPRSTVATITGIDGHLGLLYSRLPALAPADSTGPGGTTGVGRTLSTAHFDQYSPEGGCEECHGVGGTWRAAKDLIITHPRLPLFRGASPWFAKWRSGEHRFVPALAEKRGVDLEQPWQDLPQAFRDAVLYGTGDEVIEATYEFQARKKTGKWTYSDKGPMRGALAEVERVAGAASSQSAKQRYMAYMRKQPCATCDGTGFGEAARTVSLGGVSYQRLVTFEVDTVRNWTGDVLAGLSGMQREVGEPLLEALGARLTLLQRLGVGHVQLFRSAASLSGGELQRTRLAAQLSTDLTGMTFVLDEPGTGLHPADKAHLLDIAHELRGSGNTVLLVDHDPELIARADWIIDMGPGAGRLGGHLLASGPPAEISRCEESTTGRYLARRGRRVDRIPRPVDDRTPSLVLRAVEVHNVTADEIRFPLGRLTCLTGVSGSGKSSVLRDVLGVGVAACLDGGTADTVGQVDGVEHLSWLAVVDQDPIGRTPRSNPATYTKAFDIIRRLFASADQARALGLDASAFSFNAPGGRCEACTGYGRRLVDMHFLPDVWVICDACEGRRFTPEVLTVTYRGLTIDAVLGLTVAEAVEHFQEPRQLATTLRALDKVGLGYLQLGQSATDLSGGEAQRLKLANAIQRGTRGHSSGLILMDEPVSGLHPADIQQMVDAFELLLEAGHTVIVAEHDLHVAAASDWVVDLGPGAGAAGGRVMAEGPPREVARTNGVTAAYLRRVEAGEPLLGTQVVPGTPVPGTPGAPPQGESGPAARG	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	161.27	gnl|BL_ORD_ID|900|hsp_num:0	974			369	699	lincomycin; clindamycin; celesticetin
BGC0000414.1|Quinocarcin_11 # 14729 # 15673 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.698	BGC0000414.1|Quinocarcin_11 	14729	15673	+	Loose	450	28.4906	mreA	26.09	3007050	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGCAGCACCGACCCACGGACCGACAGCCCTTGCCGAGACCTCCGACGACGACCTCGAAGCGCTCCTGATGATCAGGCACTTCGAGCTCGCGCTTCTCGACCTGTTCTCGACCGGGAAGCTCAACGGAACCACCCACACCTGCCTGGGACAGGAGTACATACCGGTCGCCCTCGCCCCGTTGACCGAAGGGGATTTCGTCTTCAGCAACCACCGCGGGCATGGCCACTACCTTGCCCGGTTCCACGATCCGGCGGGGCTCCTCGCCGAGATCATGGGCCGGGACGGGGCTGTCTGCCGGGGTGTCGGAGGAAGCCAGCACATCTACCGCGACGGCTTCCTCTCCACCGGCATCCAAGGCCAGAGCCTGCCGGTCGCCGTGGGCGTCGCCCTTCACCTCAAGCGAGCCGGTGACCACCGCATCGCCGTGGCCTACACCGGCGACGGAACGTGGGGCGAAGGCGCCGTGTACGAAGCCCTCAACATGGCGCAGCTGTGGCGCGTGCCGCTCCTCGTCGTGGTGGAACACAACGGTATCGCCCAGTCCACGCCCACCCACCGGCAGATGGCGGGCACCATCGCCGACCGGGCCCGCGCCTTCGGTATCCCGCACGTCGAACTCGGCGGCGTGGGCGTCGACGCCCTCCGTGCCGAACTCGCTCCCCGCGTGGACGAGATGCGCACCCGGCAGACCCCGCTCGTGATCCAGTTCAATACCGCCCGCGTCGGCCCGCACAGCAAGGGCGACGACACCCGGTCGGCACCCGAGCTGCGACTCGCCGGCGGCCGCGACTGGTACCCCGCGTACGCCGCCGCCCTCGGTGCACGTTTCGAGGCCGTCGACGCCAAGCAGCGCGACCACATTGCCGAGCTGGTCCACCGCGTCGAGGCCCGGCCGCCATCCACCTGGCACCACGACGACACGGGAGGAGCCACAGCGGCGTGA	MAAPTHGPTALAETSDDDLEALLMIRHFELALLDLFSTGKLNGTTHTCLGQEYIPVALAPLTEGDFVFSNHRGHGHYLARFHDPAGLLAEIMGRDGAVCRGVGGSQHIYRDGFLSTGIQGQSLPVAVGVALHLKRAGDHRIAVAYTGDGTWGEGAVYEALNMAQLWRVPLLVVVEHNGIAQSTPTHRQMAGTIADRARAFGIPHVELGGVGVDALRAELAPRVDEMRTRQTPLVIQFNTARVGPHSKGDDTRSAPELRLAGGRDWYPAYAAALGARFEAVDAKQRDHIAELVHRVEARPPSTWHHDDTGGATAA	MMKIHYINDYKDIQAKEDCVLVLGYFDGLHLGHKALFDKAKKIATEKNLKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQLITEGNVEKANQLLGYEFSTCGMVVHGDARGRTIGFPTANLAPINRTYLPADGVYISNVLINGKYYRAMTSIGKNITFGGTELRLEANIFDFDGDIYGETIEIFWLKRIREMVKFNGIDDLVKQLKKDKEIALNWKKDSQTL	100.96	gnl|BL_ORD_ID|4755|hsp_num:0	5749			222	465	
BGC0000414.1|Quinocarcin_13 # 15897 # 18080 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.687	BGC0000414.1|Quinocarcin_13 	15897	18080	+	Loose	300	27.7202	tet(M)	33.33	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACCCGCACCAGGACCTCCGCGCCCCGCGTTGCCGCCGCCCTCAACGAGGCCCTCCACACTCTCTTCGCCCACGACGAGGACCTCCACCTACTGGGCGAGGACATCGTCGACCCCTACGGAGGCGCCTTCAAGATCACTAAAGGGCTCTCCACCCGCTACCCCGACCGCGTACTGGCCACCCCGCTGAGCGAGGGCGGCATCATCGGCGTTGCCGGTGGCCTCGCCCTCTGCGGCACTCCCGTGATCGCCGAGATCATGTTCGGGGACTTCGTGGCCCTCGGCTTCGACCAGATCCTCAACTTCGCCTCGAAGTCGGTGTCCATGTACGGGACACACGTCCCCATGCCGCTCGTGATCCGCTGCCCGGTGGGCGGCAACCGCGGTTACGGCCCCACCCACAGCCAGAGCCCGCAGAAACATTTCATCGGCATCCCGAACCTCACTCTGTACGAGTTGTCGCCGTTCCATGACCCGCACGCCGTGCTGGACGAGGCGCTGCGGCGCCGGACCCCCGCCATCCTCTTCGAGGACAAGGTCCTCTACACACGCCGCATGCACCGCGCCGGCCGCCTCGACGACACCCTCGATTGCCTGCTGCACGACGGCCCGGCCGGATGGGCCCATATCCACCCCGCCACGGACAGCGGGCAGAGGCGCGCGCCGGACGCCGTGATCATCGCCGCTGGCGGCGTCGCCGACCGGGCCATCGACGCGGCACATGCGCTGGCCGCCACGCACGGGGTATCCACCCACGTTCTCGTACCCGCCCGCCTCTACCCGCTCAACCTTGACCCCGTCCTGCCGGTGTTGCGCAGCGCTCGTCGTATCGCGGTCGTGGAGGAGGGCACGGCGGGCGGCACCTGGGGCAGCCATGTGGCAGCCGCCCTCTACCCGCGGCTGTGGGAGTGGCTTGACGGGCCGATCCTGCTGCTCAGTTCGGCGGACTCCATCATTCCCACCGCCGCTCACCTCGAACAGCGGGTACTCCTGGACGCCGCCACCATCGAGGAGTCCATCGCCCAGGCCATGACAGGCCGGCCGAGGGTCCAGCCAGTGCCGAGGGGAGTCCCGACGGCGACGCACGGACCCGGGGTGACAGACACCGCCGAACCGGAGGACGGCACACCGATCAACGTGCCCAAGCTGAACAACAACGACACCTTGTACCGGGTCGTGGAGTGGCTGTACGACGAGGGTGCCTGGGTGGCGAAGGGCACAGCGGTCGTCTCCCTGGAGACCTCCAAGGCCATCCAGGACATCGATGCCTCGGAGAGCGGCTACCTCCACCGCGCCGTGCTCCCGGACGACGACGTCGGAGTCGGCGCGGTACTGGGCCACCTGCTGGCCGGCCCCCCGGACACCACCGTCGCACTGCCCCCGGAGCCAGCCGCTGCTCCGCATCCCGCACCGGACACCGTGCGGCCGGAGCCGCCCGCGCGGCGCGGTGCGCCTGCCTCGCCGCAACCTGCGGAGGACACCTCGACACGGCGCCACCCACTGGACCGGGCGCAGCTCGGCACCGCCGAGGCAGTCGCCCGAAGCCACGCGGAGATCCCCGCAGCCTTCACCGCCTTACGCGTTGACGTGGACCGCGCGCTCGACGCGCTCGACGCGCTCAGTGAGGCGAGCGATGCCATCGTCGGTCTCCCGGACGCCCTGGTGAAGGCCGTGGCCACCGCGCACGAGAGCTTCCCACTGTTTTTCGGCCGACTGGAATCGGACGGCCGCTCGGTCGCCCTCGCCGAAGCGCCCCATGTGGGCGTGACCATCGACGTCGGATCCGGCCTCTTCGTACCGGTGGTCCACAACGCCCACACGCTTCTCATCACCGAGATCGCCGACATGCTCATGGATTTTCGGATGACGGCGTTCCGTACGGATTTCACCGCGCGACAGCTGGACGGTGGCACCATCACCATCTCCTTGAACCCGGACCCGGGCGTCGTGCTGGTCCAGCCCATTGTCCTGTGGCCCCAGCTGTGCATGCTGTCGGTGGGCGCGGTCCATCCGGAAGTGTGCATCGATGCGGACACGGGGACTCCGACAGAGCACCGGTGCATCACCTTGGGACTCGCCTACGACCACCGCGTCATCAATGGCCGCGATGCTGCACTGTTCCTCACTCACGTCAAGGAAATGTTGCAGAACGAGGAGTCACTCGCCCGTCTCCTCGACAGCTGA	MTRTRTSAPRVAAALNEALHTLFAHDEDLHLLGEDIVDPYGGAFKITKGLSTRYPDRVLATPLSEGGIIGVAGGLALCGTPVIAEIMFGDFVALGFDQILNFASKSVSMYGTHVPMPLVIRCPVGGNRGYGPTHSQSPQKHFIGIPNLTLYELSPFHDPHAVLDEALRRRTPAILFEDKVLYTRRMHRAGRLDDTLDCLLHDGPAGWAHIHPATDSGQRRAPDAVIIAAGGVADRAIDAAHALAATHGVSTHVLVPARLYPLNLDPVLPVLRSARRIAVVEEGTAGGTWGSHVAAALYPRLWEWLDGPILLLSSADSIIPTAAHLEQRVLLDAATIEESIAQAMTGRPRVQPVPRGVPTATHGPGVTDTAEPEDGTPINVPKLNNNDTLYRVVEWLYDEGAWVAKGTAVVSLETSKAIQDIDASESGYLHRAVLPDDDVGVGAVLGHLLAGPPDTTVALPPEPAAAPHPAPDTVRPEPPARRGAPASPQPAEDTSTRRHPLDRAQLGTAEAVARSHAEIPAAFTALRVDVDRALDALDALSEASDAIVGLPDALVKAVATAHESFPLFFGRLESDGRSVALAEAPHVGVTIDVGSGLFVPVVHNAHTLLITEIADMLMDFRMTAFRTDFTARQLDGGTITISLNPDPGVVLVQPIVLWPQLCMLSVGAVHPEVCIDADTGTPTEHRCITLGLAYDHRVINGRDAALFLTHVKEMLQNEESLARLLDS	MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGITSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYTSGKLLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	113.77	gnl|BL_ORD_ID|1674|hsp_num:0	1692			1083	1239	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000414.1|Quinocarcin_14 # 18120 # 19154 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.645	BGC0000414.1|Quinocarcin_14 	18120	19154	+	Loose	500	28.4906	OXA-358	28.57	3001545	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAAACCCGGGCCGCACTTTGGGCTGCTCTCCCTCGGAGCAGCCCACGGCGAACGCGTCGCGGTCGCCGACATCGTGTCCGAGTACACCGCTGACACACAACGGGTACTGGAATACGGGTACCGTAATATCCATCGCTGTCCACCGGACGTGAGTCTGTGCGACCTCGCCGAGGAAGCGGCCCGTGAGGCCCTTGCCATGGCCGACATCACCGCCGACCAGCTGGATCTTTTGGTTCTAGCCATCACCGACATTCCCGAGTATCTCTACTGGGACCCCAGCACCCACGTACAGCACCGGTTGGGTGCCCGGCGGGCCGAGACCGTGCTGATCGCCCAGGGATGCATTGGGGGGATTACCTGCCTCGACCAGGTCGCCGGACGATTCGCCACCCACCCGGACTACCAGAATGCCCTGGTCATCGGCGTGAATCGTACCTGCGAGGCGTACTGGAACCGTATGGAGACGCATTCGCTGATGTTCTCCGACGGTGCCGCAGCGGCGGTGCTTCGTCGGGGCCATGACGCGTACACCTGGCGGGCCGTCGAGACGATCAGCGACGGACGGTACTCCGACTTCTTTCTGCTCGAGCAGGGTGGGGCGGCAGTACCCTTCACCGCGGACGGCGCTGAGACCGGGATGTCGCCCACTGTGCGCGACGCCTGGGACATGATGGAGTTCTTCGACTACGACACCGACCGCTTCGCAACTTTCGTGGACCTGATGAACACTCGTGTGGCGGAAGTCGTTGCACGCGCCTGCCGGCGGATCGGCGCCGATGTATCCGACCTGTCCCGGGTCGTCTTCCTCAACGATAACGCGCGCACGCTGAAGGACGTGTCCGGGAAGATCGGTGTGCCGCTCGACCGGACCAACTTCGACATCTCCCTGGAGCATGGCCACTTCGGCGCCGCCGACCACCTCTTCAATCTCCGCAGGCACATATTGGACGACGCCGTGAAGCCCGGCGACCTCATCGCGCTCGCCGGAATGGGCCGGGGCATGCACTGGGCGTGCGCGCTCATCGAGGTCTGA	MKPGPHFGLLSLGAAHGERVAVADIVSEYTADTQRVLEYGYRNIHRCPPDVSLCDLAEEAAREALAMADITADQLDLLVLAITDIPEYLYWDPSTHVQHRLGARRAETVLIAQGCIGGITCLDQVAGRFATHPDYQNALVIGVNRTCEAYWNRMETHSLMFSDGAAAAVLRRGHDAYTWRAVETISDGRYSDFFLLEQGGAAVPFTADGAETGMSPTVRDAWDMMEFFDYDTDRFATFVDLMNTRVAEVVARACRRIGADVSDLSRVVFLNDNARTLKDVSGKIGVPLDRTNFDISLEHGHFGAADHLFNLRRHILDDAVKPGDLIALAGMGRGMHWACALIEV	MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSQEVKRVGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL	126.01	gnl|BL_ORD_ID|287|hsp_num:0	318			306	558	cloxacillin; oxacillin; cefalotin
BGC0000414.1|Quinocarcin_15 # 19233 # 19970 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.629	BGC0000414.1|Quinocarcin_15 	19233	19970	-	Loose	400	42.3578	Erm(31)	39.22	3000598	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACAACTACGCGATGGACAGCTACGGAAACGCCTTTGCGTTCCTCTTCGACCTCGTCAACAGCGACAAGAACGAGGTGAAGGCGGCGGTCGCGCTGCTCGGCGAATATGCACAGAACGACGAGCCGGTACTGGAGGCGGGCGTCGGAACCGGCCGTGTCGCCATCCCGCTGGCCGAGACGGGAATTCCGGTCTACGGCGTCGAAATCAGCGAGAAGATGGCGGAGCGGCTTCGGGCGAAGCCGGAGGGGCACCGGGTGCGGCTCGTGGTCGGCGACATGGCCACTGTCCGGTTCGATGTGTCGTTCGGCCTCATCTACATCGCTCAGGGCGGCCTGCACAGTCTTCTCACCGGCCAGGAGCAGACCGACTGTCTCAAGAACCTCGCCGGTCAGCTCAAGGCCGGCGGTCATCTGGTGATCGAGAGTCTGACGCTAGATCAGAGTCGTTTCACCCGCGACCAGTACCTCGACATCACCATGATGGACGTCGGCTACGTCGCCCTGTCCGCCGCGGTGCACGAACCGGAGCAGCAGGTGGTCAACGTACAGTCCATCCTCATCTCACAAGATGGGGTGCAGCTCTTCCCCCTGCGGTACCGGCACTACTCGCCGACCGAACTCGATGCCATGGCGGCCCAGGCCGGACTCACTCTCCTTGGGCGATGGTCGGACTGGGACAAGACTCCTCCGCACCGTGAGCAGAAGCGGTTCATCTCCGTATACACCTCAGCCTGA	MDNYAMDSYGNAFAFLFDLVNSDKNEVKAAVALLGEYAQNDEPVLEAGVGTGRVAIPLAETGIPVYGVEISEKMAERLRAKPEGHRVRLVVGDMATVRFDVSFGLIYIAQGGLHSLLTGQEQTDCLKNLAGQLKAGGHLVIESLTLDQSRFTRDQYLDITMMDVGYVALSAAVHEPEQQVVNVQSILISQDGVQLFPLRYRHYSPTELDAMAAQAGLTLLGRWSDWDKTPPHREQKRFISVYTSA	MAFSPQGGRHELGQNFLVDRSVIDEIDGLVARTKGPILEIGPGDGALTLPLSRHGRPITAVELDGRRAQRLGARTPGHVTVVHHDFLQYPLPRNPHVVVGNVPFHLTTAIMRRLLDAQHWHTAVLLVQWEVARRRAGVGGSTLLTAGWAPWYEFDLHSRVPARAFRPMPGVDGGVLAIRRRSAPLVGQVKTYQDFVRQVFTGKGNGLKEILRRTGRISQRDLATWLRRNEISPHALPKDLKPGQWASLWELTGGTADGSFDGTAGGGAAGSHGAARVGAGHPGGRVSASRRGVPQARRGRGHAVRSSTGTEPRWGRGRAESA	76.09	gnl|BL_ORD_ID|1068|hsp_num:0	1156			81	234	narbomycin; methymycin; pikromycin
BGC0000414.1|Quinocarcin_16 # 20001 # 23303 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.659	BGC0000414.1|Quinocarcin_16 	20001	23303	-	Loose	1000	100.138	almE	23.54	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAGCACAGCCGAAGGACACGCATCCGGTCTAGAGGCGCTTGGCCGCAGGCTCGTGGAACGCTGGCGCGACCACTCGTACCTTGCCGGAGAGTCCCCCGCCCCGGCCGCGAACGCGTCCACCGCACCGGCCAGCTCCGTCCAGGAGGGTATCTGGTTGTTCGAACGGCTCCACCCCGGCACCTCGGTCAATCACCTGACCTACTGCGGCCGTGTGGAGGGCGACATCAATGTTTACGCCCTCGCCGAGGCCCTGCGCGTGGTGTGTACGCGGCACGACATCCTGCGGACAACGTTCCGTGAGGACCCGGCCGACGGCACGTTGCACCAGGTCGTGCACCCCGGGCTCATCGTACGCCCGAGCGTGCAGGACCTGACCGGTCTGCCCGGGGAGGAACGTGAACTGAAGGCGGCCCAGGCACACCGCGCCCTGGCATCCGAGCCGTTCGACCTGGCCACCGGCCCGCTGCTGCGGATGGCCGTCCACCACCTCTCACCCCGCCGGTCCTTCCTGATCGTGGTCGCACACCACCTGATCGCGGACGGCTGGTCCCTGTCGGTCTTCTTCCGCGAGTTGGCCGCCGCCTACGAGGGCGAGGACGTCGCCGTAACGCTCGGAAAGCCGCAGCAGTACGTGGCCGCCGAGAGACAGCACAGGGGCGGGAACGTCGACGTGGACGACGGCGCTGATCCCAGTGCCGACACTGCTGCCGCTACTGCTCCCGATGAGGACGCGGTGACGTACTGGCGGCGGATGCTGAGCGGCCGGCTGTCGGTCGAGCTGCCCACGGACCACCCCCGGCCCGCGACCCCGCGATTCCGGTCCGGAACGGTCGCCGTGGCCGTCCCGCCGGATGTCGCGGCAAGCGTACGGGCAGTTGCCGCTGCGACGGAGGCGACCCCGTTCATGGTCCTCCTTACAGCATTTCAGATGCTTCTGGCACGCATGACCGGTCAGGAGGACATCTCCGTCGGCTCCCCGACGGCGATGCGGCAACGCGCCCACGCCCCACGGGTACTCGGTCCGCTGGTCAACATGCTGGTACTGCGCACTGATCTGACCGGTGACCCAACGTTCCGGGAGGCGTTGGAGCGAACGCGCCGGACGTGCCTGGGCGCGTACGCGCATCAGGAGGTGCCCTTCGAAAAGTTGGTGGAGGAACTCCAGCCGGAGCGGGACCTCAGCCGAAGCCCTCTGTTCCAGACCATGCTTGTGCTCCAGGACCAGCCCGCCGAACTCCGGCTGGGCGACCTCCTCGTCACGCCTGTGCAGATGGAGCCGGACACTGTGCAACGCGACGTGGAGTTGTACCTGTGGCACGGCGAGGGCATCACGGGTCATCTCACCTACAACACCGACCTCTTCACCCCCCAAACAGCACAACGATTCACCTCCCGGTTCCTGACACTGCTGACAGCCGCCGTGACCAACCCCGACACACAACTGAGCCACCTCCCAGTCATGGACGAAACGGAACAACGGCTGCTGGCCGGTCTCTCGTCCGGACCCACCACCCCCGAAGTCCCTGAGGGGTGTGTGCACGAGTGGTTCGAGGCGCAGGCCGACCGCACTCCCGACACCGTCGCCGTCCGCGCTGTTGACGGCACCCTCACCTACCGGCAGCTGGACGAACGCGCAAACCAGCTGGCCCACCACCTGCGCGAGCACGGCGTGGGACCGGAAACACTGGTAGGAATATGCCTGCCACGCACACTGGACCTGGTGACATCACTGCTCGCGGTACTCAAGGCCGGCGGCGCCTACGTCCCCATCGACCCCGCCTACCCCCGAACACGCATCACCTACACACTCAACGACGCCCGCGCCACCGTCCTGATCACCACCCAGAACCTCACCGCCACCCTGCCCGAAGGAACCTGGCACGCCCTCACCCTCGACACCACCCACACCGGCCGGCACCCAACCCGACGCCCCACGAACAAAACAGTACCGGCAAACCTCGCCTACACGATCTACACCTCCGGCTCGACCGGCCGGCCCAAAGGCGTAATGATCGAACACCGCCAGACCACCACCCTCCTCGCCTGGGCCCACACCACCTACACCCCCGCCCAGCTCACCAACGTCCTCGCCTCCACCTCCATCTGCTTCGACCTGTCCGTCTTCGAAATCTTCGCCCCCCTCACCACAGGCGGCTCCATCACCCTCACCCACACCAACGCCCTCGACCTGCTCACCCCACCCCACCCCGACATCACCCTCATCAACACCGTCCCCTCCATCATCCAGGAACTCCACACCCACAACGCCATCCCACCCACCACAACCACCATCAACCTCGCCGGCGAACCCCTGCCCCCACACCTCGTCAACACCCTCCACAACCACCCCCACATCCACACCATCAACAACCTCTACGGACCCACCGAAGACACCACCTACTCCACCCACGCCACCACCACACCCAACGACCCCCGCACCCCCATCGGACACCCCCTCCCCCACACCCACGCACACATCCTCGACCACAACCTCAACCCCGTCCCCACCGGCACCATCGGCGAGCTCTACCTCACCAGCCACCGCACCACCCGCGGCTACCACAACCACCCCCGCCAAACCGCCGAACACTACCTCCCCAACCCCCACAACCCCCACACCCGCCTCTACCGCACCGGTGACCTCGCCCGCTGGCGCCCCGACGGCCAACTCGACTACCACGGCCGCACCGACAACCAAATCAAAATCAACGGCCACCGCATCGAACCCGCCGAAATAGAAACCACCCTCCTCACCCACCCCCACGTCCAAGAAACCACCATCACCACCCACACCACACCCCACACCACCCAACTCATCGCCTACATCACCGCACCCCAGCTCAACAACAACCCCACACCCCTCAAAAACCACCTCACCCAACACCTCCCCCGCCACCTCCACCCCCACCACTACATCTTCCTCGACCAACTCCCCCGCACCCCCAACCAAAAAATCGACCACAAAGCCCTCCCCAAACCCAACACCCACACCACCACAACAAACCACCAAACACCCAAAACCCGAACCGAAAAACTCATCGCCACCATCTGGCAGGAAACCCTCCACATCCAAACCATCTCCACGAACGACGACTTCTTCACACTCGGCGGCCACTCCCTCCTCGCCGCCCGCATCGCCACACGCCTCACCACCCAAACAGGCACCACCATCCCCGTCCGACTCCTCTTCGAACACCCCACCATCGCCGAACTGGCCCAGCACATACCGGACCCCATCAGTGAGGCGCGCACGTCGATTCCGCGTCTGTCCCGCAAGCTCCGCGGGACGGGAGAGAGCTGA	MSTAEGHASGLEALGRRLVERWRDHSYLAGESPAPAANASTAPASSVQEGIWLFERLHPGTSVNHLTYCGRVEGDINVYALAEALRVVCTRHDILRTTFREDPADGTLHQVVHPGLIVRPSVQDLTGLPGEERELKAAQAHRALASEPFDLATGPLLRMAVHHLSPRRSFLIVVAHHLIADGWSLSVFFRELAAAYEGEDVAVTLGKPQQYVAAERQHRGGNVDVDDGADPSADTAAATAPDEDAVTYWRRMLSGRLSVELPTDHPRPATPRFRSGTVAVAVPPDVAASVRAVAAATEATPFMVLLTAFQMLLARMTGQEDISVGSPTAMRQRAHAPRVLGPLVNMLVLRTDLTGDPTFREALERTRRTCLGAYAHQEVPFEKLVEELQPERDLSRSPLFQTMLVLQDQPAELRLGDLLVTPVQMEPDTVQRDVELYLWHGEGITGHLTYNTDLFTPQTAQRFTSRFLTLLTAAVTNPDTQLSHLPVMDETEQRLLAGLSSGPTTPEVPEGCVHEWFEAQADRTPDTVAVRAVDGTLTYRQLDERANQLAHHLREHGVGPETLVGICLPRTLDLVTSLLAVLKAGGAYVPIDPAYPRTRITYTLNDARATVLITTQNLTATLPEGTWHALTLDTTHTGRHPTRRPTNKTVPANLAYTIYTSGSTGRPKGVMIEHRQTTTLLAWAHTTYTPAQLTNVLASTSICFDLSVFEIFAPLTTGGSITLTHTNALDLLTPPHPDITLINTVPSIIQELHTHNAIPPTTTTINLAGEPLPPHLVNTLHNHPHIHTINNLYGPTEDTTYSTHATTTPNDPRTPIGHPLPHTHAHILDHNLNPVPTGTIGELYLTSHRTTRGYHNHPRQTAEHYLPNPHNPHTRLYRTGDLARWRPDGQLDYHGRTDNQIKINGHRIEPAEIETTLLTHPHVQETTITTHTTPHTTQLIAYITAPQLNNNPTPLKNHLTQHLPRHLHPHHYIFLDQLPRTPNQKIDHKALPKPNTHTTTTNHQTPKTRTEKLIATIWQETLHIQTISTNDDFFTLGGHSLLAARIATRLTTQTGTTIPVRLLFEHPTIAELAQHIPDPISEARTSIPRLSRKLRGTGES	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	197.84	gnl|BL_ORD_ID|4935|hsp_num:0	5928			120	1668	colistin A; colistin B
BGC0000414.1|Quinocarcin_17 # 23300 # 25504 # -1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.711	BGC0000414.1|Quinocarcin_17 	23300	25504	-	Loose	1000	40.817	almE	22.26	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGACGGGATCGCAGAGGCGACACCGACCGTCGGGACATCAGGGAGGACAGACCTACGCCTCCCTCGCCCGGCTTTTGCTCGACCGCGCACAGGGCCTCCCGGACAGCACGGCCTACGAGTTCCTCCACAGCGACGGGACCGTAGACACGATCAGCTACGGAACGCTGTACGAGCGGGCCGCGGAGGTGGCCGCCCAGGTCGCCCTGGGCGGGGACCGCCCCGGTCCGGTGCTGCTGCTGTACCCGCCGGGACTCGGTTTCGTCACCGCGCTGTGGGGGTGCCTGTTGGCCGGTGCCCCGGCCGTACCCGCCTATCCGCCGCTGCCCCGCCCGGGCGACCGCGGAACCATCCGGTTCCGGCACATCCTCGCCGACGTGCGCCCCTCGCACGTCCTCGTCGATCCGTTCATCCGGGACGTGCTGGCAGACATCGACGCGGGACCGGCGCTGCCCAGCCTGCTGTGCCCGGACCCGGGCACAGCGGTCGGCGGAGAAGCGGGTCGGCCGACCGCTTTCGGCCGGGGGCAGACCATCGCCGCCCCGCCCCGGGTGCTGCCCGGAACCGACGACGTCGCGCTGGTCCAGTACACCTCCGGGAGCACCAGCGATCCCAAGGGTGTCGTCCTCCGCCACAGCAACCTGTTGCACAACATGCGTGCGATCACAGAAGTGTTCGGGCTGAACGAGGACACCCGCGCGGTGTCGTGGCTGCCTCCGTACCACGACATGGGCCTCATCGGCTGCATCCTCACGCCCGTCCTCGTCGGCTTCCCCATCCGGCTGATGTCCCCGCTGGATTTCCTCAAGAGCCCCCTGAGCTGGCTGCGGCAGATCAGCACTCTGCAGGTGACCGCCGCCGGCGGTCCCAACTTCGCGTACGACCTGTGCGTGCGGCGAGCACGGAACGAGGACCTGCAGGACCTGGACCTGAGCAGTTGGAAAGTGGCCTTCAACGGAGCCGAGCCGGTACAGCGGCGCACGATGGAGGAGTTCGCCCGCCGGTTCGCTCCGCACGGCTTCCGCCCGTCCGCATTCCTGCCGTGCTACGGGCTCGCCGAGGCGACGCTGATTGCCACCGGACACCACTGGGACCCCACGGAACCGGACGACACCCCGGCACCCGGGGCCGCGCCCCGGGTGAGCTGCGGCCCCGCCGCCGGTGGCACGAGCGTCGCCGTGGTCGACCCCGCGGACGGCCGCCCACTGTCCGACGGCGAGGAAGGCGAGATCTGGCTGCGCGGCCCCAGCATCACAGACGGCTACTGGAACGGAACGGGGGCATCGCGGACCGGGTCCGCAGATCGGCCCGGAGAAGCGTTCGGCGATCGGTCCGGAGAACTGTTCGGCGACTTGGACGGCCTGCGCCATCTGCGCACCGGCGACCTGGGGTACCTGCGCGACGGCGAACTGTTCGTCACCGGCAGGCGCAAGGATGTCCTCGTGCACCGGGGAGTGAACCACCACGCACACGACATCGAGTCCGCCGCAGTCAGAGGGAACCCGCATGTGCGCCCCACGGCCGCCGCGTTCATGGTCGAAGACCCCGAGCCCGTGGTCGTCCTGGCCGTCGAGCGGCCCCCCGCTCGGGCGGGCACGGACGAGGAGACCGCGCGGGTGCTGCGTACAAGGGTCCTCGAGGCCACTGGAGTACGGCTCGATGTGGTGGTGCTGTGTGCGCCGCGCGCTATTCCGAAGACGACCAGTGGGAAGGTGCAGCGGACGCTGGCGCGGGACCGCTTCCTCGCTGGTGAGCTGGACGGAGCCGTGACGATCGGGGCGCCGACGGGGCTGGGCGGCGGGTCCGTCGAGCCGAACGGGTCGGGGCTGGCGGACGGGGATCGAGGTTCCGCTGCGGCCTCGGCCTCTGCGTCAGCCTCCGGTCCGTCGGTGGCCGAGGTGGCGGAACCCCTCAGCACGCTGGTCGCCGGGGTCTTCGCGGGCGTCTGCGAGGTGCCCGAGTGCGGGACCGACCAGCGCCTCGCCGACATCGGCGGGGACTCGATACGCGCGGCCGAAATCGCCGCGATCGTGGAGCGGGCCATGGACCTGCCCGTACCCATCGAGTCGGTGCTGGCCACCGCGACCCCGGACGCACTCGCACGGCACCTGCTCACCCACTGGGCCGAACAAGGTGTCGGCACACCATCGGTACTCGGGCGGCTGGAAGAACTGTCGATGACGGCACCGGAAGGAACCACCCTGTGA	MTGSQRRHRPSGHQGGQTYASLARLLLDRAQGLPDSTAYEFLHSDGTVDTISYGTLYERAAEVAAQVALGGDRPGPVLLLYPPGLGFVTALWGCLLAGAPAVPAYPPLPRPGDRGTIRFRHILADVRPSHVLVDPFIRDVLADIDAGPALPSLLCPDPGTAVGGEAGRPTAFGRGQTIAAPPRVLPGTDDVALVQYTSGSTSDPKGVVLRHSNLLHNMRAITEVFGLNEDTRAVSWLPPYHDMGLIGCILTPVLVGFPIRLMSPLDFLKSPLSWLRQISTLQVTAAGGPNFAYDLCVRRARNEDLQDLDLSSWKVAFNGAEPVQRRTMEEFARRFAPHGFRPSAFLPCYGLAEATLIATGHHWDPTEPDDTPAPGAAPRVSCGPAAGGTSVAVVDPADGRPLSDGEEGEIWLRGPSITDGYWNGTGASRTGSADRPGEAFGDRSGELFGDLDGLRHLRTGDLGYLRDGELFVTGRRKDVLVHRGVNHHAHDIESAAVRGNPHVRPTAAAFMVEDPEPVVVLAVERPPARAGTDEETARVLRTRVLEATGVRLDVVVLCAPRAIPKTTSGKVQRTLARDRFLAGELDGAVTIGAPTGLGGGSVEPNGSGLADGDRGSAAASASASASGPSVAEVAEPLSTLVAGVFAGVCEVPECGTDQRLADIGGDSIRAAEIAAIVERAMDLPVPIESVLATATPDALARHLLTHWAEQGVGTPSVLGRLEELSMTAPEGTTL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	132.01	gnl|BL_ORD_ID|4935|hsp_num:0	5928			567	1380	colistin A; colistin B
BGC0000414.1|Quinocarcin_19 # 26565 # 29936 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.706	BGC0000414.1|Quinocarcin_19 	26565	29936	+	Loose	1000	49.2914	almE	22.05	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGTAGCTCGTCATATGTCGGTGCGCTCGGGGCCGGCCACGGCCATGATTTCAGCGACTTCTACATCTTTCCGGCCTCCTCGGCCCAGTCCCGTCTCTGGTTCCTGTGCGAACTCGAACCGGAAAGCAACGCCGCGTACAACGTCATCAGCGCGGTGCGACTCCTCGGGACGCTGGACCGGTTGCGCCTGCAGCAGGCCGTCGACGTCGTGGTCGCCCGGCACGAGAGCCTGCGCACCGGTGTCGCCCTCGTCGACGGCACGCCCCAGCAGGTCGTACTGCCGTCCGCCCTTGTGGCCCTGCCCACGGTTGACCACACTGCTGCCGACGAGGAAACCAGGCGCCGCGCGGTGACCGACATCGTGCGTGAGGAGGCATCGCGCCCGTTCACCCTGCACCGACCTCCGCTGGTGCGCATGGTGCTCCTGCGCCTGGCGGATGACGAGCATGTACTGGTCGTCACCATGCACCACACCGTGTGCGACGGATGGTCGACCGAACTCTTCTTCCGTGACCTGGCCACCAGCTATGCCGGCCTCATGGCTGGCGGCAGCGGAGAGCTGAAGGAACTGCCCATCCAGTACGCCGACTACGTGGCCTGGCAGAACGAACAACTCAGCGGCGACCGCCTCGATACTCTTCTCGCCCATTGGCGGGAGCGGCTGGCCGGCGTGCCCCTGCTGGATCTGCCCACCGACCTGCCCCGCCCGCCTGTACGCACCCTGCGCGGCGCTCAGTGCACCGCCGACCTCTCTGCGGACCTCACCGGCCGCCTCGGCCGCGTCGCCCAGGACCGCGGCGCGACCATCTTCATGCTGCTGTTGACGGCCTTCAAGGCGCTCCTCGCCGCTGGCAGCGGACAGTGCGACATCGCGGTTGGCACCCCGGTGGCTGGACGGGAGCACCCCGAGGCCGAGGAGCTCATCGGCTTCTTCGCCAACACCCTCGTGCTGCGCAGCCGGATCGCACCGGATGAGACGTTCACCGAGGCGCTGGACACCGTACGCGCCACCTGCCTGGACGCCTTCTCGCACCAGGACGTGCCCTTCGACCGTCTCGTCGAGGAACTGCGTCCGCCCCGCGACCTCAGCCGCACGCCCTTGTTCCAGGCGATGTTCTCCCTTCAGAACACCCCTGGCATCACCCTCGACCTGCCCGGACTGCGCCTCGAACCGGTCGAGACCGAGCACGCCTCCGCCAAGTTCGACCTGTGGCTGACGTGCCTGCCCACCGGAGACGGGCTGCGGCTCCAACTGGAGTACAACACCGACCTGTTCGACGCGGCCACCGCCGACCGGCTGCTCCGTCACTACTGTGGCCTGCTCGACCATGTCGCGGACGACCCCGTACGGCCCCTGAACCGGCTTCTGCGCGGAGGTGACGCGGCCGGTGCTCCGGCACCGCAGCCGCTGCCGGATCGGACCGCCACCACAGTCGCCACGCTGCTCGACGCCCATGTAGAACACGATCCGTCCGCGATCGCTGTGGTCGAGCCCGACAGTATTCTGACGCGTCGTCAACTGCGAACGCTTGCACACCGGCTGGCGCACCGGCTCCGCGCCGCGGGGGCCGCCCCCGGAACGGTCGTCGCCGTCAGTGTGCCGCGCGGCACCCTCGACGCCGTCGTCGCTGTATATGCTGTCCTCGCCTCCGGAGCCGCACTCGCGTACGTCTCGCCCGACGACGATCGGCACGTCGCATGGGTCCTCGCCGACGCCGCCCCGGTGGTCCTCCTGACCACTGGGACAAGGGGCGCGCAGGGCGGGCCGGACGCGCAGGGCGCCCACATGGTGCCGCTGCCGATGACGGTGACCATGGGCGGCGACGCCACCGGTCAGGAGCCCGACGCTCCACCCCTGTCGGTTCCGCGGTCCGGCGACACGGCGTGTGTGGTTTACGCATTCGGTAGGAGCGCTCGGCCGACGGGCGTGCGGATCGGGCACCGTGCCTTCGCGGCGTCCCTGGTCGAGGCCGCGCGCCGCACCGACCTCACCTCCGACGACACAGTGGCCGTCGTTGCGGACGAGGACGCTCACGAGGATGGGCTCACCCCGTGGCGTCTGCTGCTGCCGCTCACTGCCGGAGTGCGCGCCGTGTTCCCGTCCGCGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAGGACGACAAAGGTGATACGGGCGTCACCGACGTCACCGACGCCACCGTCCTCGTGGCCTCCACTGGCACCTGGCGGCGGCTTGCGGACGAAGGGGCACTGGACACCGGGTCCCGCGTCGTGGCCATCGGGGAACCGCTGCCTGCCACGGCCGCCGCCCGCCCCGGACTGTGGCGCCTCCACGGCTCCGCCGAGGCCCTGGCGTCCGGGGCCGCGTACGAGGACCGGGGCCCGCTGTCCGGCCTCGGCCGTGCCGCCGGGCACCTGCGCCGATACATCCTCGACCCCGATCTGTGCCCAGTGCCCGACGGCATGGTTGGTGACCTGTACGTGAGCGGACCCGGCCTCGCCGACGGCTACCACGCCCGCCCGGCCGACACCGCCCGCCGATTCCTGCCCGACCCATACGCCCCCGAGCCCGGCGCCCGTATGCACCGTACTGGCGACCTCTGCCAGTACGGTTCCGACGGCGAGGTGCGGTTCGTCGGCCGGGCGGGCGGCGAGCTCCGGATCCGGGACCGCTGGATCGATCCGGCAGAGCCCGAGGCGCTCCTGCGGGAGCATCCGCTGGTCCGGCGGGCGGCCGTCGTCGCTGGTGAGTTCGGTGACGACATCAGGCTCGTCGGCTGGCTCGAACCCGACCGTTCCGCGGCACCGCCCGACGAACCCGTCACTGACGGCGAACTCCTCCGCCTGCTGCGGCAGTCCCTGAGCGAGCAGCTGCCCGCCCACCTCGTGCCCAGCGTCTTCGGGGTCCTCGACGCCCTGCCCCTGGCGTCGGACGGCACCGTCGACCGGCAGGCGCTGCGGGCCCGCAAGGACGAGGCCACCTTCGGACTGACCGACTCCACGCCGCCGCGCGACGCCATTGAGCGACGCATGGTCTCCCTCTTCCTGGAGGTCCTGCCCTACCCGGAGATCGGTGTGCACGCGAACTTCTTCGCCCTCGGCGGGCACTCCCTGCTTGCTGCCAAACTCCTCGGCCGGGTGCGCACGGAATTCGGGACTGCTGTGCCTGTACGGGAGTTCTTCAAACGGTCCACGCCGGCAGGTCTCGCCGAGGCCCTGCGCGGCGCCCAGGAGACCCGCCGTACCGGCCGCGGCACCGCAGCGGCCGACGGCGCCGCCCTCAACGGCATGTCGGACGAGGAGGTCACCCGCCTGCTCCAGCGGCACCTGCGGTGA	MSSSSYVGALGAGHGHDFSDFYIFPASSAQSRLWFLCELEPESNAAYNVISAVRLLGTLDRLRLQQAVDVVVARHESLRTGVALVDGTPQQVVLPSALVALPTVDHTAADEETRRRAVTDIVREEASRPFTLHRPPLVRMVLLRLADDEHVLVVTMHHTVCDGWSTELFFRDLATSYAGLMAGGSGELKELPIQYADYVAWQNEQLSGDRLDTLLAHWRERLAGVPLLDLPTDLPRPPVRTLRGAQCTADLSADLTGRLGRVAQDRGATIFMLLLTAFKALLAAGSGQCDIAVGTPVAGREHPEAEELIGFFANTLVLRSRIAPDETFTEALDTVRATCLDAFSHQDVPFDRLVEELRPPRDLSRTPLFQAMFSLQNTPGITLDLPGLRLEPVETEHASAKFDLWLTCLPTGDGLRLQLEYNTDLFDAATADRLLRHYCGLLDHVADDPVRPLNRLLRGGDAAGAPAPQPLPDRTATTVATLLDAHVEHDPSAIAVVEPDSILTRRQLRTLAHRLAHRLRAAGAAPGTVVAVSVPRGTLDAVVAVYAVLASGAALAYVSPDDDRHVAWVLADAAPVVLLTTGTRGAQGGPDAQGAHMVPLPMTVTMGGDATGQEPDAPPLSVPRSGDTACVVYAFGRSARPTGVRIGHRAFAASLVEAARRTDLTSDDTVAVVADEDAHEDGLTPWRLLLPLTAGVRAVFPSADDKDDKDDKDDKDDKDDKDDKDDKDDKDDKGDTGVTDVTDATVLVASTGTWRRLADEGALDTGSRVVAIGEPLPATAAARPGLWRLHGSAEALASGAAYEDRGPLSGLGRAAGHLRRYILDPDLCPVPDGMVGDLYVSGPGLADGYHARPADTARRFLPDPYAPEPGARMHRTGDLCQYGSDGEVRFVGRAGGELRIRDRWIDPAEPEALLREHPLVRRAAVVAGEFGDDIRLVGWLEPDRSAAPPDEPVTDGELLRLLRQSLSEQLPAHLVPSVFGVLDALPLASDGTVDRQALRARKDEATFGLTDSTPPRDAIERRMVSLFLEVLPYPEIGVHANFFALGGHSLLAAKLLGRVRTEFGTAVPVREFFKRSTPAGLAEALRGAQETRRTGRGTAAADGAALNGMSDEEVTRLLQRHLR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	201.98	gnl|BL_ORD_ID|4935|hsp_num:0	5928			969	1656	colistin A; colistin B
BGC0000414.1|Quinocarcin_20 # 30018 # 30227 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.662	BGC0000414.1|Quinocarcin_20 	30018	30227	+	Loose	900	24.6386	lin	31.71	3004651	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGGGATTGACAGCCCGGACACCGTCTTCCAGGTCGTCGTCAACGAGGAAGGCCAGTATTCCATCTGGTTCGCCGACCGTGACCTGCCCGTCGGATGGACCGCAGACGGGCCGACCGGCACCAAAACCGAGTGCCTGGAGCACATCGAGAAGGTGTGGACCGACATGCGCCCGCGCTCCGTCCGCACAGCGCCGGTCGACGCCGCCTGA	MGIDSPDTVFQVVVNEEGQYSIWFADRDLPVGWTADGPTGTKTECLEHIEKVWTDMRPRSVRTAPVDAA	MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS	13.19	gnl|BL_ORD_ID|2202|hsp_num:0	3361			246	369	lincomycin
BGC0000414.1|Quinocarcin_21 # 30377 # 34837 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=11bp;gc_cont=0.697	BGC0000414.1|Quinocarcin_21 	30377	34837	+	Loose	1000	129.413	almE	27.78	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCCAGCAGCCACGTGATCTAAACGAGATGTCCCCGGAGGAGAAGCGGCACCTGCTCGCCGAACTCCTCGACAAGTCACCCGGTGAGGCACCTGCCACCGTTCTGCTGGAACAGCGCCGTCTGTGGATGCTGCTCCAGCTGGCCGAGACCCAGCCGTGGCAGGTGTTCCGGGCCCTGCGCATCACGGGGCGGCTGGACCTCGCCGCACTTCAGCTCGCCCTCACCGAGCTGATCCAGCGCAACGAGGTCCTGCGCATGTCGTTCGTGGACGTGGGCGGGCAACCCGTCGGCACTGCCGTCCCCTCCCTCACCCTCGGCATGCCCGTCGTGGACCAGACCGGCGCCGACGCGGACACCGAACTCGCCCGTCTTGCCAAGCTGGAGGCCGGGACCCGCTTCGACATCGCCAAGGGCCCCTTGGTCCGCGCCACCGTCGTACGCCACGGCGACGAGGACCACACCCTGTTGCTCACTCTCCACCAGCTCGTCGCCGATCGGCGGTCCCTGTATTTGTTCGTCGACGAACTGATGAGCGTGTACGCCGCCCTGGTCGAAAACCGGCGTCCCGACCTGCCCCCCGTGCCCGTCGGCTTCACCGAGTTGGTCGAGACCCAGCAGCAGTGGCTCGCTGGCGACGAAGCTGCCAAGGATGCCGCCTACTGGCGCGACCGCATGGCTGGGCTCACCCCGCTCGAACTGTTCACCGACCGCCCACGCCCCTCGCTGAAGACCATCGCCGCCGCCACCACCGAGGTCGGTATCGACGCAGCGACCGCCGACGCCCTCGCCCGCTACACCGAACAGACCGGCCACCGGTCCCCCGACGTCCTGCTGGCCTGCTACGCCGCCGTCCTCGCCCGCCACGCCCAGCAGCGTGACCTGGCCGTCGGCGTGCCCGTGCCCAGCACGCTCTACGAGGAGGCGCACACTCTCGTCGGCCCGCTGGACAACAACCTGCCGCTGCGACTGGACCTGTCCGGCGACCCCTCCCTCGACCAGCTGGTGGCTCTCGTTGCCGACGCCAGGCAGGCCGCGGTCGCCCACGGCGGGCTACCGTTCGACCGTATTGTGGAAGAGGCGCAGCCGCAGCGCGATCTGCGGTACACGCCGCTGTTCCAGACCACGTTCCGCTACGAGGAGGAGCCGGCGGCGCGGGACCTGCCCGGAGCCCGGGTCACCTCCCTCGACCTCGACACCGGCTGGACGCCGCACGACATCGACCTGTACGCCGTGCGGCGCGGCGACAGCCTGCAGCTCCAGGCCCACTACAACACCGACCTGTTCGACGCCGTCACCGTTGAACGGCTGGTGCGGCACATCGCGGTTCTCCTCGCCGCCGCCGCCGCCGAACCCACCCGCCCGCTGTCCGCGTTCCCGCTTCTCGCCGTCGGCGAACGGGACCTGGTGGTCACCACCTGGAACGACAGCGCGCAGCCTTACCCCGCGGAGCGCCTCCTGCACGAGCTCGTCCAGGAAAGCGCCCGCCGGGTGCCCGACGAGGCCGCCGTGGTCTGCGGCGACCAGAGGCTGACGTACCGGCAGGTCAACGGGCGGGCCAACGTCGTGGCGCAGCAGCTCGCCGAGCACGGCGCCGGTCCCGAGGCCCGGGTCGCCGTGCTTGCCGACCGGACCGCCGACCCCGTCGTCGGCCTGCTCGGCGTGCTGAAGTCCGGCGCTGCGTACGTCCCCATGGACCCGGCGTACCCCGCCGACCGTATCGGCTACACCCTGGACGACGCCGGCATCGGCATCCTGGTGGGCTCCCGCGCGGCCATCGACCGGCTTCCCAACCTGGACCGCGACGTCACTGTGGTCGAGATACCGGGCACCGACCCCGACACGCCCGTACCCGACCCGGACAGCGCCGCGTCTCCCACCAACCTGGCCTACCTCATCTACACCTCGGGCTCCACCGGGCGCCCCAAGGGCGTCGCCGTCGAGCACCGCCAAATCGTCCACTCCACCTGTGCCCGCACTGCCGTCGAAGGCCCCGGCCGGCCGGAGCGCTACCTCGTGCTCGCCCCGCTCACCTTCGACGCCTCTGCGGGCGGGCTGTACTGGACGCTGTCCCGCGGCGGCACCGTCGTCCTGCCCACCGCCCACGAGGTGTACGACCCACGGCTGCTCGGCAAGCTGATCCGCAGCCACGCCGTCACCCACGTCGACGGAGTGCCCTCACAGTACAGCGTCCTGCTGGAGACCGACCTCGGGCAGCACGATTCGGTGCGCTGCTGCATCCTCGCAGGCGAGGCCATGCCCCCCGCCCTGGTCGCCGAACACCACCGGCGCTCGCCGCAAGCGGCCCTCTTCAACGAGTACGGACCGACCGAGGCCACCGTCTGGGCCGCGGTGCACCCCTGCCGCCCGGAGGACACCGACCTTGCGCGCGTCCCCATCGGACGGCCCATTCCCAACGCCCGCCTGCTGCTCCTGGACGAACACCTCAACCCCGTCCCGCCCGGCGTCGCCGGCGAGCTGTACCTCGCGGGCGACGGCGTCACCCGCGGCTACCCCGGCAAACCTGGTGAGACCGCCCAGCGCTTCCTGCCCGACCCGTACACCGAACGGCCCGGCGCCCGCATGTACCGCACCGGCGACCGCGCCCGGCACCTGAGCGACGGGTCCGTGGAGTTCCTCGGCCGCGTCGACAACCAGGTCAAGATCCGCGGCTTTCGGGTGGAGCTCGCCGAGATCGAGAATGTGCTGCTGCGCCATCCCCTCATCAACGAGGCCGTGGTCCGGCTCAGCGAGGAACGCCCCGGTGTGCAGCGCCTCACCGGGTACGCGGTGCCCACGAGCGGCCGCGTCCTGTCCCAGGAGGCGCTCACCACGCACTGCGCTGCCGAGCTGCCGGACTACATGGTGCCGTCCCACTTCTTCATCCTGGAACGGATGCCGCTCACCCGGCACGGCAAGGTCGACACGGATGCCCTGCCCTCCCCGCAGGAGATCCAGGTCGGCGGCTACGTCGAGCCGCGCACCCAGCTGGAGGCCGAGATCGCCGAGACGCTCGGCGACGTCCTGGGCATCCAGCGGGTCAGCGCCACCGCCAGCTTCTTCGACCTTGGCGGCGACTCCCTGCTGGTGGCCCGCCTCACTGCACGTCTCTCGCGCGAGCACGACGTGGACATCCCCATCGACGAAATCTTCCGCGTCCCGACCGTCGAGGGCATCGCCCGGACCGTCGAGGTCCACCAGCGTAAGCAGGGCCAGGTCGACAGCGACGTACGGTATGCGCAGCAGCTCGCCGAACTGCTCGCCGACGTCAAGCTCGACCCGGACATCCGCGCCGACGGGCTGCCGCACGCCGACTACCTCAGCCCCCGGCACATCCTCGTCACCGGAGCCACCGGCTACCTCGGTGCGTTCCTCGTGGTCGAGCTGATGAAGCGCACCGATGCCGTCGTGCACTGCCTGGTCCGGGCCGACGACTCCGAGGCCGCCATCGAGCGCCTCGAACAGGTCCTGCGCAACTACCGTGCCTGGGACGAGTCGTACCGTCCACGGCTGCGCCCGGTCGTCGGCGACCTCGCGAAGCCCTTCCTGGACCTCCCCCGGGAGTCCTTCGACCAACTGGCCGAGGAGATCGACTCGATCTACCACAGCGGCGCCATCGTCAACTTCACCTTCCCGTACGAGGCGATGAAGCCCGCCAACGTGCACGGCACGGAGGAGCTGCTCAGGTTCGCCACCCGCAGTCGCCTGAAGGCATTCCACTTGGTCTCCAGCGTCGACGTCTTCATGGGCACTGGCGCCGAGCGGCCGTTCACCGAGGTGGACCTGCCCGAGAAACCCATTCGCATCCCCACCGGCTACCCGCGCACCAAGTGGGTTGCCGAGAAGCTGGTGGCGATCGCCCGCGACCGAGGCGTTCCCGTCACCGTTCAGAGGCCCTGGATGATCACGGGCCACACCAAGACCGGTGCTTCCCACCACACCGACTATCTGTACGTCTACCTGAAGGGCTTCCTGGACCTTGGCGTCATGCCGCTCTTCGACGACGTCATCAACGCGGTACCGGTGGACTTCACCGCGGAGGCCATCGTCTACACCTCACTGCGTGCGGAGAACTTCGGCAAGAACTTCAACATCACCAACCCGAGTCCCACCACCATGTCGCAGTGTTACGAGTGGCTGCGCACCTTCGGCTATCCCCTGAACGTCATTGACGAAGAGGAGGCCCGGCAGCGCGCGCTGTCCGTGGAACAGGACCACATCCTTTTCCCGATGACGCCCATGCTCCGGGTCGCGTCCATGCGGCACGCGGCCCTCGACCCGGAGCTGCAGAAACGGGTGAACCCGCAGGACGAGTGCCGCGTCCTGACCGAGGCGCTGGCGGGCTCCGACATCGAGTGCCCGCCCGTGAACGAGGAGTGGGCGCACTCCTGCTTCCGCTACCTGGTTGACATCGGCTTCCTTCCCGACCCCGACAACGAGTCGGCCGTCACGGCCGGCTGA	MSQQPRDLNEMSPEEKRHLLAELLDKSPGEAPATVLLEQRRLWMLLQLAETQPWQVFRALRITGRLDLAALQLALTELIQRNEVLRMSFVDVGGQPVGTAVPSLTLGMPVVDQTGADADTELARLAKLEAGTRFDIAKGPLVRATVVRHGDEDHTLLLTLHQLVADRRSLYLFVDELMSVYAALVENRRPDLPPVPVGFTELVETQQQWLAGDEAAKDAAYWRDRMAGLTPLELFTDRPRPSLKTIAAATTEVGIDAATADALARYTEQTGHRSPDVLLACYAAVLARHAQQRDLAVGVPVPSTLYEEAHTLVGPLDNNLPLRLDLSGDPSLDQLVALVADARQAAVAHGGLPFDRIVEEAQPQRDLRYTPLFQTTFRYEEEPAARDLPGARVTSLDLDTGWTPHDIDLYAVRRGDSLQLQAHYNTDLFDAVTVERLVRHIAVLLAAAAAEPTRPLSAFPLLAVGERDLVVTTWNDSAQPYPAERLLHELVQESARRVPDEAAVVCGDQRLTYRQVNGRANVVAQQLAEHGAGPEARVAVLADRTADPVVGLLGVLKSGAAYVPMDPAYPADRIGYTLDDAGIGILVGSRAAIDRLPNLDRDVTVVEIPGTDPDTPVPDPDSAASPTNLAYLIYTSGSTGRPKGVAVEHRQIVHSTCARTAVEGPGRPERYLVLAPLTFDASAGGLYWTLSRGGTVVLPTAHEVYDPRLLGKLIRSHAVTHVDGVPSQYSVLLETDLGQHDSVRCCILAGEAMPPALVAEHHRRSPQAALFNEYGPTEATVWAAVHPCRPEDTDLARVPIGRPIPNARLLLLDEHLNPVPPGVAGELYLAGDGVTRGYPGKPGETAQRFLPDPYTERPGARMYRTGDRARHLSDGSVEFLGRVDNQVKIRGFRVELAEIENVLLRHPLINEAVVRLSEERPGVQRLTGYAVPTSGRVLSQEALTTHCAAELPDYMVPSHFFILERMPLTRHGKVDTDALPSPQEIQVGGYVEPRTQLEAEIAETLGDVLGIQRVSATASFFDLGGDSLLVARLTARLSREHDVDIPIDEIFRVPTVEGIARTVEVHQRKQGQVDSDVRYAQQLAELLADVKLDPDIRADGLPHADYLSPRHILVTGATGYLGAFLVVELMKRTDAVVHCLVRADDSEAAIERLEQVLRNYRAWDESYRPRLRPVVGDLAKPFLDLPRESFDQLAEEIDSIYHSGAIVNFTFPYEAMKPANVHGTEELLRFATRSRLKAFHLVSSVDVFMGTGAERPFTEVDLPEKPIRIPTGYPRTKWVAEKLVAIARDRGVPVTVQRPWMITGHTKTGASHHTDYLYVYLKGFLDLGVMPLFDDVINAVPVDFTAEAIVYTSLRAENFGKNFNITNPSPTTMSQCYEWLRTFGYPLNVIDEEEARQRALSVEQDHILFPMTPMLRVASMRHAALDPELQKRVNPQDECRVLTEALAGSDIECPPVNEEWAHSCFRYLVDIGFLPDPDNESAVTAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	267.27	gnl|BL_ORD_ID|4935|hsp_num:0	5928			234	1629	colistin A; colistin B
BGC0000414.1|Quinocarcin_23 # 36043 # 38760 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.737	BGC0000414.1|Quinocarcin_23 	36043	38760	+	Loose	1000	117.857	almE	27.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGTCGTCCTTCCGGCCCCAACCCACCGCGCCCGCCAGGTGGGCCTGGCGGATCAGCGGCGGCCTCTCCGAGCCCCTGCTGCGCCGCGCCCTCGGCGCCACCGGCATCCCGGTCGCGCTGGGCGCGGTCGACCTCAGCCGCACGGCCGACCTCTCCGACGCCCTCGGCGTCACCGCGGTGCGTGAGGCACGGCTGATCGACGACGCCGGGGCACCCGGCGCCCGGCTTTGCCTCGCCCGCCTCGGCGACGCCGCACACGCCCTGCTCGTCACCACCCGGCGGACGCTCGGTGCCCCGGCTCAGCGGGCCCTCGTCGGCGCGCTGCTCCGTGGCTGCGGCACGGGAGCGGACCAGGACGGGGAGGCCGCCCGTACAGTGGCCCAGTTGCTGCGAGAGGCATCCGCCCATGCCCCGGACGCCCCGCCGACCCCCGGGTGGGAATGGCCCGCGGACGGGCCCAGCCCCCACGCGCGAAACCGACGCGCGGAATACGTGACGCTGGCCGGGGAGGTGCCCGCCGCCCTGACGGCTTGGTGCCACACCCGGGGCGTCGAGCTCTGGCAGGCGCTGCTCGCCGGGGTCGTCGCCGTACTGGCCCGCTACGGCGGGGCGCCGTACCCCGCCGTAGCCGTGGACGTCCCGGCGGCCACCCACACCGCCCAAGTGCCGGGACCGCGCGGACTGCGGCTGCACTGGACCGACACCGGAACCACAGCCACCCTCACCAGGGCTCTGGTGGACGCCCTGCGCACGGACCGCCCTGCGGAGAGCTGCGCCCCCGAAAGCTGCCCGGTGTTGTTCTCGTACGCCGGTGACGATCCCGGCACGAGGGCCGGCCTCCGCGCCGAACCGGTCCCCGTCACCACCGGCTGGGCCGACCATGACGTGAGCATCACTGCCCACCGCCTCGGGGACAGGTTCCACGTACGGATCGCGTACGACACCGACACCGTCACCCACCACAGCGCCGAACGCCTCGCCGAACGGCTCCTCGCGATGTGGGAGCGCTGGCCCGGCGAACCCGCCCTCGCCACACTGACGGCTCTGACCTTCGCAGAGCACCGCCGTGTCCTTACCGACGGGCGGGGCCCGGCGGAGCCCTGGCCCGATGTGTGCGTGCACTCCCTCATCGAGGAGCGCGCCTGCCGTACACCTGGCCGGATGGCGGTCGTCTGCGGCGGGGACCGGTTGACCTACGGCGAACTGGACGCGCTGGCGAACCGGACGGCCCGGCGGCTACGGCAGCTGGGGGCACGCCCCGAGGACGCGGTCGCCGTCATGGCACCCAGGTCCACCGACGCCGTGGTCGCCATCCTCGCCGTGCTGAAGGCGGGCGCTGGTTACGTCCCTATCGACCCGTCCTACCCTGCCGAGCGCATCCACCATGTGCTGCGCGACTCCGGGGCCCGGCTGGCCGTCGGGGTCCCCGACACCCTGCGCGCGCTGCCCTCACTCGAAGCGGTGACCGCCGTGGACCTGCTCGGTGACGAGGTGGCGGCCGAGGAATCCGCAGCGCTCGAACCCCTCGCCGGGCCCGGTAACCTCGCGTACGTCATGTACACCTCGGGGTCGACGGGCCGGCCCAAGGGGGTCGCCGTCCCGCACCGCGCGCTCGTGCTGTCCAACGCGGCCAGGAGCATCGGCGGGGACCCGCCCGACGTGGACCTGCTTACCATGCCGCTGTGCTTCGACGGCTCGATGAGCGGCATGTACTGGACGCTCACCGGTGGTGGGACCCTTGTGCTGCCCACCGACGACGAGGTGCGCGACCCCCGCAAGGTCGTGGCGCTGGCCGCTTCCTGGCCGGTCACCAACGTCCACTCGATCCCGTCGTACTACGCCCTGCTTCTGGACTCCTGCGACGAGGACGACCTGCCCGCGCTGCGGCACGTCTCGGTGGGCGGAGAGCCGCTGCCGCCCCGCCTGGTCGGCCGCCATCTCGCCACCAGTCCCCACGCGCTGCTGCTCAACGACTACGGGCCGACCGAGACCACCGTATGGGCCTCCGCCCACGCGTGTACGCCCGCCGACGCCTCCTCCGAGTCCGTGCCCATCGGCCGACCCCTGCCGAACTACCGGCTGTACGTCTTGGACGAGGGCCTGCGACTCGTCCCGCCCGGCCTGCCGGGTGAGCTGTACATCGGTGGCCCCGGCGTTGCCCGCGGTTACCTGGGCCGCGCCGCCCTGACCGCGGGGGTGTTCGCCCCCGACCCGTACGGGTCGGGGCCCGGCGCCCGCCTCTACCGCACCGGGGACCGGGCGCGACACCGTGCCGACGGCATCGTGGAACTGCTGGGACGCGTTGACGACCAGGTCAAGATCCGGGGCTTCCGGGTCGAGCTCGGCGAGGTCGAGAGCGTCCTGCTCCGCCACTCGGCGATCGCCGAGGCGGCCGTCCTGCTGAGCAGGAGCCAGCCCGGTGCGCCCCGGCTGATCGCGTACGTCGTCCTTCAGGACGACACCGCGGCGGAACCGGACGTACGGGCCTGGATCGACCGCGCCCTCCCGTCGTACATGCGGCCCGACACGGTACAGGTGCTGTCGTCCCTGCCCAGGAATCACAACGGCAAGATCGACACCCGTGCCCTCCCGGGCGCCTCCGGTTCGCTCCCCGGGAACGTACGCCCGCCGAGGCGGAGCCCGTCCGTCGATGGCTTGACCATCGGTCAGGTGGACGCCCTGTTGAGCCAGTTGGCGGCACGCCGTCCGGCCTTGTGA	MSSFRPQPTAPARWAWRISGGLSEPLLRRALGATGIPVALGAVDLSRTADLSDALGVTAVREARLIDDAGAPGARLCLARLGDAAHALLVTTRRTLGAPAQRALVGALLRGCGTGADQDGEAARTVAQLLREASAHAPDAPPTPGWEWPADGPSPHARNRRAEYVTLAGEVPAALTAWCHTRGVELWQALLAGVVAVLARYGGAPYPAVAVDVPAATHTAQVPGPRGLRLHWTDTGTTATLTRALVDALRTDRPAESCAPESCPVLFSYAGDDPGTRAGLRAEPVPVTTGWADHDVSITAHRLGDRFHVRIAYDTDTVTHHSAERLAERLLAMWERWPGEPALATLTALTFAEHRRVLTDGRGPAEPWPDVCVHSLIEERACRTPGRMAVVCGGDRLTYGELDALANRTARRLRQLGARPEDAVAVMAPRSTDAVVAILAVLKAGAGYVPIDPSYPAERIHHVLRDSGARLAVGVPDTLRALPSLEAVTAVDLLGDEVAAEESAALEPLAGPGNLAYVMYTSGSTGRPKGVAVPHRALVLSNAARSIGGDPPDVDLLTMPLCFDGSMSGMYWTLTGGGTLVLPTDDEVRDPRKVVALAASWPVTNVHSIPSYYALLLDSCDEDDLPALRHVSVGGEPLPPRLVGRHLATSPHALLLNDYGPTETTVWASAHACTPADASSESVPIGRPLPNYRLYVLDEGLRLVPPGLPGELYIGGPGVARGYLGRAALTAGVFAPDPYGSGPGARLYRTGDRARHRADGIVELLGRVDDQVKIRGFRVELGEVESVLLRHSAIAEAAVLLSRSQPGAPRLIAYVVLQDDTAAEPDVRAWIDRALPSYMRPDTVQVLSSLPRNHNGKIDTRALPGASGSLPGNVRPPRRSPSVDGLTIGQVDALLSQLAARRPAL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	162.77	gnl|BL_ORD_ID|4935|hsp_num:0	5928			237	1647	colistin A; colistin B
BGC0000414.1|Quinocarcin_24 # 38842 # 39630 # -1 # ID=1_24;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.674	BGC0000414.1|Quinocarcin_24 	38842	39630	-	Loose	600	29.261	emtA	23.64	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	TTGTTCTTCCGCGTCCTTGGCCCACTGGAAGTGGTCGTCGGCGGGGAACCCTTCCCGCTGCGGCGCAATCGACAACTCACCGTCCTGGCGATGCTTCTCCTCAACGCAGGGAAGCCCGTCTCCGTCCCCCGTCTCGTCGAAGCCGTGTGGGGTGGCCGCCCACCCAGGACCGCCGCCGCACAGATCCAGACCTGCATATGGTCGCTGCGCAAGATGTTTGTCGCCTCGGGAGCGGACGAGGCGATCATCGAGACCAAACCTTCCGGCTACATCATGCAGCCGCATGACGACCAACTCGACATGGTCCAGTTCGACCGCCTCGTGGAGGAAGCCAGGGCCGTCGGCGCCAGACTGGACCGTGCGACCGCCATCTCCGCCTACCGGCGAGCACTGGGTATGTACCGCGGACCTGTACTCGCCGAGATCTCCAGTCCTGCGGTGCAGGCGATCGCCTCTCTCTGCGAGGAGCGCCGGCTCACCGTCCTGGAGGACTGCATCGACCTGGAGTTGAGCGTCGGCCTGCACGGCGAACTCGTGGGCAGGCTCATGGAGCTGGTCCACGATCACCCCCTGCGGGAGCGTTTCTGCGGCCAGTTGATGTTAGCCCTGTACGGGGACGACCGGCGGGCCGAGGCGCTCGCCGCGTACCGGACGACCCGCCAGACGCTCGTGGCCCAGCTGGGGCTGGAGCCGGGGGTGCGGCTCCAGGAACTGCATCGCAAGATCCTCACCGGGGAGCTCGACTCCCCTCACCGGGCGGCGGGCCACTTCGCTGCGTACGCGGGATGA	MFFRVLGPLEVVVGGEPFPLRRNRQLTVLAMLLLNAGKPVSVPRLVEAVWGGRPPRTAAAQIQTCIWSLRKMFVASGADEAIIETKPSGYIMQPHDDQLDMVQFDRLVEEARAVGARLDRATAISAYRRALGMYRGPVLAEISSPAVQAIASLCEERRLTVLEDCIDLELSVGLHGELVGRLMELVHDHPLRERFCGQLMLALYGDDRRAEALAAYRTTRQTLVAQLGLEPGVRLQELHRKILTGELDSPHRAAGHFAAYAG	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	76.83	gnl|BL_ORD_ID|2212|hsp_num:0	3368			699	861	evernimicin
BGC0000414.1|Quinocarcin_25 # 39979 # 40506 # 1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.684	BGC0000414.1|Quinocarcin_25 	39979	40506	+	Loose	1900	28.8758	mexN	30.59	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGACTCGCCATGCGAAGGACCGTGAACGGGGGGACCGTCAAGCGCGGGACCCCGAGGGGCAGAACCGTGAGCAAACGGTCAGGCCGCGCCCGGGCGAGATTGACCGGCGCCTGGGTGAACTGATCTCCGCCCTCTACCCCGACGAGCGCAAACGCCCCGGCTATGTGCGCTTGGCCAAGGAGATCCGGGAGGCCACCGGGGGGTCCATCTCGGGCACGTACCTGTGGGAGCTGGCCACCGGCAAGAAGACCAACGTCACCCTGGAGCAGCTCTCGGTGCTGGCGGAGTTCTTCGGTGTTCCACTGGAGTACTTCCTCAACGAGGAGGTCGCCTCGCGGGTCAATGCCCAGCTCAGGTTGGCCACGGCGCTGCGCGACACCCAGGTGCGCAACTTGGCCCTGCGCGCCGAGGGTCTCTCTCAGGGCACCCTGGAGGCGCTGCTCGTCATGGTGAACGAAGCCCGCAAGCTCCAAGGTCTGCCACCCGTGGCGGACCCGGCGGGCGACCCCGCCCCCGAGGACGGTTGA	MTRHAKDRERGDRQARDPEGQNREQTVRPRPGEIDRRLGELISALYPDERKRPGYVRLAKEIREATGGSISGTYLWELATGKKTNVTLEQLSVLAEFFGVPLEYFLNEEVASRVNAQLRLATALRDTQVRNLALRAEGLSQGTLEALLVMVNEARKLQGLPPVADPAGDPAPEDG	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	16.89	gnl|BL_ORD_ID|2021|hsp_num:0	2217			1728	1983	chloramphenicol; thiamphenicol
BGC0000414.1|Quinocarcin_26 # 40568 # 41086 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.688	BGC0000414.1|Quinocarcin_26 	40568	41086	+	Loose	770	26.5646	mdsA	40.0	3000789	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGCACCATGACCGGGAGCTCCGGCGCCGCTGCCGGGCGGTGCTCAAGCGGCTGCCGTTACCCCACCCGTTCTCCGTGGAGGCGCTGTGCCGCAGTCTCGCGGAAGAACGGGGACGTCCGCTTTACACACATCCGTTGCCGACCCAGGCCGTGGCGGCGGGTGCGTGCGGCCTGTGGCTCGCGACCCCGGCCGGGGACCACATCTTCTCCGAGGTCGGCACCAGTCGCCCGCACCAGGAGCACATCATGCTCCACGAGATCGGCCACATGCTGTTCGACCATCACACGGTTACGGCCGGCGGCGCCGACCCCGTCCGTGCGCTGTTGCCCGACCTCGACGGTCAGTTGGTCGAGCGGCTGCTCGCTCGCACCAGCTACACCACCCAGCAGGAGAGGGAAGCGGAGATACTCGCCAGTCTCATACGGATCGAGGCCGCCAAGGCGTCAGTGGGCCGCAGAGGCGGAATGTCCGGCCTGGAAGAGGCGCTCGGGTTCGGTACGTCCCATGACGCCTGA	MPHHDRELRRRCRAVLKRLPLPHPFSVEALCRSLAEERGRPLYTHPLPTQAVAAGACGLWLATPAGDHIFSEVGTSRPHQEHIMLHEIGHMLFDHHTVTAGGADPVRALLPDLDGQLVERLLARTSYTTQQEREAEILASLIRIEAAKASVGRRGGMSGLEEALGFGTSHDA	MRRTFKIMLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFLAAPETVELRSRVGGTLDAISVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLARQAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPIAGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPPVVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEPRETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGFRVVTQGVLPGEKIILKGLVRPGMTVAPRLVPMRQNVTDKQTATLTKADGDSAPKAVRQ	42.16	gnl|BL_ORD_ID|389|hsp_num:0	429			843	948	chloramphenicol
BGC0000414.1|Quinocarcin_27 # 41076 # 42320 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0000414.1|Quinocarcin_27 	41076	42320	+	Loose	500	26.1794	OXA-653	40.0	3005342	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGCCTGAGGCGGTACGGGCTCTCGGGGACAGGCTCCAACTGATCAGCGTCCTGTGCGTCTGGTTCGCCGTCCTGGTCCGGGCCCCGTCGGCGTACCAGTCCCCTCGGCACCGCGGCCTGTGGCTGGCCCTGGCGACGGCCGGTGCCGCCATGACCCTCAGCCTCACCCCTGTTCGTGACGCCGTACCGCGCCTGTCCGGCATCGAGGACGCAGTCGCACTGACCGCCAACCTGTTCGGTGTGCTGTCGGTGGTGGCAATCCTGGACTTTGTCGGGGTCGCCACGGGCGGCGCGAGAGCGCGTGGCGACCGAGGCGGGAACGTGGGCGGAGAGGCAGGCGATAGGAGTGGACGTCGGGTGCGTGTCGTTCTCCTCGGCTCCGCTTCTGCCGTCGTCGGCGTTCTCGTCCTCTGTGACCTGACCGTGCCGCCCCACACAGGTCACGGCATCCCGCCGCACGGGCCGCCCGTCCCGTCACTGACGTACTGGCTGCTCCTGATCGCCACCCATACGATCGCGGACGTCCTGTGCGTGTGGGTGTGCTACACCCACAGCCGTCGCCACGACGACCGCTCCATAGCCACCAGCCTCCGGCTGTTCGGCCTCGGCACTGCGTTCGCGGTCGTCTACTGGACGGGCTTCCTGCTCTACCTGCCGACCCGGTCCGCCTGGATCCTCTCTGTCCAGCCGATCGTCATGGCCCTGCACGGAGTGCTGCGCGCCGCCGCGGTCCTCATTCCCACTGTCCTCGCGGTGCGGCGTGAGTCGCGCGAGGCCGCGGTGTTCTGGCAACTGTGGCCCCTGTGGCGTGACCTCGTCCGGGCGGTGCCCCACATCGCCCTGTCCGCTCCCCGGCCCAGACTGCTGGAACTGATCTGGCCGCGCGGCTCCTGGGCTCTGCTTGCGTACCGCAAGATCATAGAGATCCGTGACGCCTTCCTCGTGCTGCGCGACTGTTTCCCGCCCCACCTGCTGCAGAGCGCGCGTCACTACGCGAAGGCATCCCGTGTGCCTGCGCGGGACGTGGAGGCGACGGTCGTCGCCTGTCTGCTGAGAAGAGTGCTCCGGGAAGCGCGCGTGCCCCGCCCGCCGAGTTCCCTGGACGTCTCAGTGACGGCGACGGGCGGAGAGGTACTGGCGGACGACACCGATTTCCTGCTGTGCGTTGCCCGGGCCTACTGCGGCATGCTGCCAAAAGGTTTCTGCGAAAGCGTCTCAGACTGGGATTTTCATGGCTGCTAA	MTPEAVRALGDRLQLISVLCVWFAVLVRAPSAYQSPRHRGLWLALATAGAAMTLSLTPVRDAVPRLSGIEDAVALTANLFGVLSVVAILDFVGVATGGARARGDRGGNVGGEAGDRSGRRVRVVLLGSASAVVGVLVLCDLTVPPHTGHGIPPHGPPVPSLTYWLLLIATHTIADVLCVWVCYTHSRRHDDRSIATSLRLFGLGTAFAVVYWTGFLLYLPTRSAWILSVQPIVMALHGVLRAAAVLIPTVLAVRRESREAAVFWQLWPLWRDLVRAVPHIALSAPRPRLLELIWPRGSWALLAYRKIIEIRDAFLVLRDCFPPHLLQSARHYAKASRVPARDVEATVVACLLRRVLREARVPRPPSSLDVSVTATGGEVLADDTDFLLCVARAYCGMLPKGFCESVSDWDFHGC	MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEGKNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMTLGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEVNFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWRMDVTPQVGWLTGWVEQANGKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII	150.55	gnl|BL_ORD_ID|3048|hsp_num:0	4074			339	429	cloxacillin; oxacillin; cefalotin
BGC0000414.1|Quinocarcin_28 # 42536 # 43657 # 1 # ID=1_28;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.668	BGC0000414.1|Quinocarcin_28 	42536	43657	+	Loose	700	72.4034	mef(D)	24.2	3005089	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCAGGTCAGCGCGGTCACGGCGATCGAGTTCCTGCCCGCGATGCTGTTCGGATTATTCGTCGGCGTCTGGGTGGACCGGCTGGATCTCCGGCGCATTCTCCTGTGGACCGACATCGGCAGATTCATTTCGCTGGGAACAATTCCCGTCGCCTACGTGCTGGACGTACTCAATTTCCCGGTGCTGTACACGGCGACTTTCTTCACCGGGCTCCTTTCCATCGTTTACGACTCCGCCTATCAGGTTCTCCTGCCGCAACTGGTGGACAAGGATCAGTTGCTCGACGCCAACGCCAAGCTCCAGATGTCGCAGTCCATTGCCAGGGGTTCCGGGCCCGCGCTTGGCGGCACGATGGTGCAATGGCTGTCGGCTCCCGTGGCGGTGGCCGTGGACGCGATGTCGTATCTGCTCTCTGCGGTGGCCGCCTTCCTCATCCGTGTTCCGCCGGTAAGGAGGAAGGCGCGGCAGGAGCGCGGCACGTTCGCCGGGGAAGTTGTTGAGGGCGTCCGCGCCATCGTGAAGCACCCCGTCCGCTGGCGCCTCTCCGCCGCTGAGGCCACAGACAACTTCTTCGGCTCGGGAGTCATTGCGCTCTATGCCCTCTACGCGACCCGGGAACTCGGCCTCTCGGCATTCCTCACCGGCGTCGTCTTCGCTGTTGGCCCGCTGGGAGCCATCGCGGCCTCCGCCGTCCTTGCCCGGGTGGGCCGGCACGACCGCCCCCGCGAGACGGTCATCGCCGGAGTGCTCATCCGCGCGGTCGGCTTCCTGATGGCGCCGTTCGCGGGCGGTTCTGCCTGGCTGGTGGTCGCCCTGCTGTGCGCTGGGCAGATCCTTGCCCAGGGCGGCCTGACCACTTTGGCGCCGGCTTCGGTGACCTGGCGTCAACTGATCACGCCCAACCACCTCCTGGGCCGCGTCCTGTCCTTCGGGATGACACTCCAGTACGGAACGATTCCTCTTGGCGCCCTCTTCGCGGGCTGGATCGGGGAGGTCTTCGGTATCCGCGCCGCCCTCGCGGTGTCGGCCTGCGGCGTCTTCTGTACCGCCCTCTGGCTCCTGGGCACCCGCAACCCTGACGCCCCGGAGCGAGCGGCGGACTCCGGCAGCATGTCGCGGTGA	MQVSAVTAIEFLPAMLFGLFVGVWVDRLDLRRILLWTDIGRFISLGTIPVAYVLDVLNFPVLYTATFFTGLLSIVYDSAYQVLLPQLVDKDQLLDANAKLQMSQSIARGSGPALGGTMVQWLSAPVAVAVDAMSYLLSAVAAFLIRVPPVRRKARQERGTFAGEVVEGVRAIVKHPVRWRLSAAEATDNFFGSGVIALYALYATRELGLSAFLTGVVFAVGPLGAIAASAVLARVGRHDRPRETVIAGVLIRAVGFLMAPFAGGSAWLVVALLCAGQILAQGGLTTLAPASVTWRQLITPNHLLGRVLSFGMTLQYGTIPLGALFAGWIGEVFGIRAALAVSACGVFCTALWLLGTRNPDAPERAADSGSMSR	MKNNKWKKKFIAIYIGQFFSLLSSAAVQFSIIWWLTDKTGGSPLVLTLAGLAGFLPQALAGPFAGTITDRYSRKLMMILADMTVALGSLILFISLYFYEINISFVILILAIRSLATAFHMPALQASIPLLVPEDDLTKAAGWGQTVSSISNITGPAVGMSILAASSIEWVLLLDVLGAVIASGILLFIYIPKIQNQNQQSIDSKGFFIEMKDGYNALVNHPILLKLTFVMTSVAVLYIPLGTYFPLITRNHFNKGVVEAGIVEIIFAVGLIIGGSFLGILGDKFNKINTMTTGILLMGIALFLTGILSPSLFYFFVVLAGLVGFSGPLFSAPFYALIQSEIEPHLLGRVFSFVTSISLLATPLGYVIAGLLIEITNVSTLFSIIGVLIIFNGIIINRLK	93.48	gnl|BL_ORD_ID|2806|hsp_num:0	3823			159	1149	
BGC0000414.1|Quinocarcin_29 # 44041 # 44265 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000414.1|Quinocarcin_29 	44041	44265	+	Loose	450	23.8682	APH(3'')-Ic	43.33	3002640	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGTCATACAGTCACGCGGAGCCGGCGGTGCCGATCATCCGGGTCTGCGAGTGCCAGGGCGTTCTCATCCTGGCCGATCCCGCCCGCCGGGGGCGCCGGCTCATGGCTGGGCATCAAGCGCAGGCTCCTGCAGGAGCTCACCCCGCCGAAAAGGCCCTCAATCAGGCACTGGCCGCAGCGCGAGCGCCCGTCGAACGCGGCGTCGCGAACCCGAAGCCCTGGTGA	MSYSHAEPAVPIIRVCECQGVLILADPARRGRRLMAGHQAQAPAGAHPAEKALNQALAAARAPVERGVANPKPW	MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNILVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPERLRFYLALDPLTWG	29.13	gnl|BL_ORD_ID|1889|hsp_num:0	2052			315	405	streptomycin
BGC0000414.1|Quinocarcin_30 # 44434 # 44811 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.643	BGC0000414.1|Quinocarcin_30 	44434	44811	+	Loose	2090	25.0238	smeB	32.76	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGTCAGTGTGCTGGTACGGGACAAACAGGTGGTCGTGATGGAACCCGGCGACGACGTTGCAGCTCAGGCCGGCGTCGGTGAGTTCCCGCGAGACCGCAGCGGTCAGGCCGACCGCCCCGAGCGCGGAGTGGATGCGCAGAGTGATCCAGCCGGCCACGTAGTCGTACGCCAGCCCTGCGGCATCCGCTTCTTCAAGTGGGACAACCAGGCTCAAGCCCTCGTGCTCGGCAACTGTGACCACAGGGGTGACGCCGGAGGGCACACTGCCCACGACTGTGGTGAACACGTATCGGCCCGGATTCAGCTCCGGGCGCATGCTGCTCAGCAGTTTCTGCAGATCACTCTCGCCAGTCACGCCGACCAGCTTACGCATTAA	MVSVLVRDKQVVVMEPGDDVAAQAGVGEFPRDRSGQADRPERGVDAQSDPAGHVVVRQPCGIRFFKWDNQAQALVLGNCDHRGDAGGHTAHDCGEHVSARIQLRAHAAQQFLQITLASHADQLTH	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	11.92	gnl|BL_ORD_ID|1813|hsp_num:0	1960			600	768	
BGC0000414.1|Quinocarcin_31 # 45200 # 45589 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.731	BGC0000414.1|Quinocarcin_31 	45200	45589	+	Loose	420	24.2534	smeR	56.25	3003066	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGATCATCACCCGTGAGGGCGACCGGCGATGCAAGCTCCGTCCGTCCCGGCGCGCGATGGCGGCACTGGTGTACCTTCGCGAACACACCACTCCGGCGAAGACCGCCGCCGGGTTCGGGACCAGCGAGTCCACCGCCCACGCCTGCACCGGCGCGGTCGTCGACCTGCTCGCCGCCCGTGCACCGGGTCCGCTGAAGACGCTGCGCGGGCACGAGCCCGACTTCGTCCTGCTCGACGGGACCCTCGCCGAGCGCGACCGGGGCGGCGACGGCCGGGCCGACTACTCCCACAAACGCCGACGCCACGGCGTGAATGTGCAGGTCGTCACCGATCCCGGCGGTCGCTGCGGCTCTCGCCGGCCCTGCCGGACCGCATTCGCGGCCTGA	MLIITREGDRRCKLRPSRRAMAALVYLREHTTPAKTAAGFGTSESTAHACTGAVVDLLAARAPGPLKTLRGHEPDFVLLDGTLAERDRGGDGRADYSHKRRRHGVNVQVVTDPGGRCGSRRPCRTAFAA	MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDLMLPQRDGVDLCRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDPGARANGGLHIDEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDELLDRLYLDHRVVVDRTVDSHVRNLRRKLADAGMEGEPIRSVYGMGYSYEP	56.33	gnl|BL_ORD_ID|1425|hsp_num:0	1550			150	198	
BGC0000414.1|Quinocarcin_32 # 46151 # 46966 # 1 # ID=1_32;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703	BGC0000414.1|Quinocarcin_32 	46151	46966	+	Loose	700	32.7278	PDC-280	25.16	3006654	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	TTGCGTGAGGGTGGTTCGCTCCCCGGGATCGTCGAGGCCGACGACCTCGGCACGTACGTCATGAAATTCACCGGCGCCGGACAGGGACGCAAGACGCTGGTCGCGGAGGTCATCTGCGGCCGGCTCGGCCGCCGGCTCGGGCTGCGGGTCCCCGACCTCGTACAGATCCAGCTCGACCCGGTCATCGGGCTCGCCGAGCCCGACCAGGAGGTGCAGGAGCTCCTGAAGGCCAGCGGCGGGCTCAACCTCGGGATGGACTTCCTGCCCGGATCGATCGGCTTCGACTCGCTCGCCTACCAGGTGGATCCGCGGGAGGCCGGACGGGTCGTCTGGTTCGACGCGCTGATCAACAACGTCGACCGGTCCTGGCGCAATCCGAACATGCTGGTCTGGCACGGTGATCTGTGGCTCATCGACCACGGTGCCACCATGATCTGGCAGCACAACTGGCCCGGCGCCCAGGCGTCCGCCGCCAAGCCGTACAACGCCTCCGACCACGCGCTCGCCCCGTTCGCGCCCGACATCGCCGCGGCCGCCGCCGAGCTGGCCCCGCTGGTCACCGAGGAACTGCTCACCGAGGTCGCCGCCGACGTCCCCGACGAGTGGCTGGTGGACGAGCCGGGCTTCGACACCACCGACGAGCTGCGCCGGGCCTATGTGGAGGCGCTGCTGCCGCGCGCCGCGACCATCCACGAGCGGATCACGATGGAGGGCCCCACCGAGCCCAGGCCGTCCCAGGCCCCCGGCTGGCTCACCGAACACCTCACACCCTGGCCGCACCCCACCAAGAAGAACGACAAGGACGGCCAGCGGTGA	MREGGSLPGIVEADDLGTYVMKFTGAGQGRKTLVAEVICGRLGRRLGLRVPDLVQIQLDPVIGLAEPDQEVQELLKASGGLNLGMDFLPGSIGFDSLAYQVDPREAGRVVWFDALINNVDRSWRNPNMLVWHGDLWLIDHGATMIWQHNWPGAQASAAKPYNASDHALAPFAPDIAAAAAELAPLVTEELLTEVAADVPDEWLVDEPGFDTTDELRRAYVEALLPRAATIHERITMEGPTEPRPSQAPGWLTEHLTPWPHPTKKNDKDGQR	MRDTRFPCLCGIAASTLLLATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQNKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDYRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	68.26	gnl|BL_ORD_ID|4344|hsp_num:0	5414			513	978	
BGC0000414.1|Quinocarcin_33 # 46963 # 47346 # 1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.740	BGC0000414.1|Quinocarcin_33 	46963	47346	+	Loose	1050	24.2534	lmrC	34.0	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGAGCGAGCGCGATGTCTTCGAGTACGCGCTGCTGCGCGTGGTGCCGCGGGTGCAGCGCGGCGAGTTCTTCAACGCGGGCGTGGTCGTCTACTGCCGTGCGCGGGGCTTCGTGGCCGCCCGCACCCATCTCGACGAGACCAAGCTGATGGCCCTGGACCCCGCCGCCGACGTGATCGGCGTACGGGCCGCCCTGCACGCCGTCGAGGGAGTGTGCCTCGGCGGAACGGACGCGGGCCAGGCGGCCCGTGACGACGCCGGCCGCCGCTTCCGGTGGCTGATCGCGCCGCGCTCCACCGTCGTTCAGCCGAGCCCCGTGCACAGCGGCCTCACGGCCGACCCGGCGGCCGAGGTCGAGCGGCTGCTCGAACTGCTGGTGCGCTGA	MSERDVFEYALLRVVPRVQRGEFFNAGVVVYCRARGFVAARTHLDETKLMALDPAADVIGVRAALHAVEGVCLGGTDAGQAARDDAGRRFRWLIAPRSTVVQPSPVHSGLTADPAAEVERLLELLVR	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	23.09	gnl|BL_ORD_ID|900|hsp_num:0	974			243	372	lincomycin; clindamycin; celesticetin
BGC0000414.1|Quinocarcin_34 # 47579 # 48340 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.696	BGC0000414.1|Quinocarcin_34 	47579	48340	+	Loose	500	26.9498	PEDO-2	47.62	3003714	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGTCCACCACCGAGCAGCGCGTCGCCATCGTGACCGGAGCGGCGCGGGGCATTGGCGCAGCCACCGCGGTACGCCTGGCGGCCGAGGGCCGCGCCGTCGCCGTACTCGACCTCGACGAGGCGGCCTGCAAGGACACCGTCGAGAAGATCACCGCCGCCGGTGGCACCGCCCTCGCGGTCGGCTGCGACGTGTCGGACAGCGCCCAGGTGGAAGCCGCGGTCGCGCGCGTCGCCGCCGAGCTCGGCGCCCCGACGATCCTCGTCAACAACGCGGGCGTACTCCGCGACAACCTGCTCTTCAAGATGACCGAGTCCGACTGGGACACCGTGATGAACGTGCACCTCAAGGGCGCGTTCCTGATGGCCAAGGCCGTTCAGAAGCACATGGTGGACGCCAAGTTCGGCCGTATCGTCTCGCTCTCCTCCTCCTCGGCGCTCGGCAACCGGGGCCAGGCCAACTACTCCGCCGTCAAGGCCGGTCTCCAGGGCTTCACCAAGACCCTCGCCAAGGAGCTCGGCAAATTCGGCATCACGGCCAACGCCGTGGCTCCCGGCTTCATCGTCACCGAGATGACCGCGCAGACCGCGGCCCGGGTCGGCATGGGCTTCGAGGAGTTCCAGGCCGCCGCCGCCACCCAGATCCCGGTGCAGCGGGTCGGCCACCCCGAGGACATCGCCAACGCCATCGCCTTCTTCACGGGCGACGAGGCCGGCTTCGTCTCCGGTCAGGTCATGTACGTCGCCGGCGGACCGCTCAACTGA	MSTTEQRVAIVTGAARGIGAATAVRLAAEGRAVAVLDLDEAACKDTVEKITAAGGTALAVGCDVSDSAQVEAAVARVAAELGAPTILVNNAGVLRDNLLFKMTESDWDTVMNVHLKGAFLMAKAVQKHMVDAKFGRIVSLSSSSALGNRGQANYSAVKAGLQGFTKTLAKELGKFGITANAVAPGFIVTEMTAQTAARVGMGFEEFQAAAATQIPVQRVGHPEDIANAIAFFTGDEAGFVSGQVMYVAGGPLN	MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTEKGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYVDEKDADALETGGKLDYELGKYGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSCSFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLDFDLWVASHASQFELHDKRKSGAPYNPKIFMDKSKFFKNLEDLENIFLEKIKN	88.77	gnl|BL_ORD_ID|2026|hsp_num:0	2229			399	462	
